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PART I 
CHAPTER I 
INTRODUCTION 
Sickle cell anemia is a molecular disease with a mutation producing an amino acid 
substitution at the /36 positions of the hemoglobin molecule (Hb) (Schechter et al., 1987). 
Sickle hemoglobin (HbS) molecule exhibits IO times higher mechanical instability than normal 
hemoglobin (HbA) (Asakura et al., 1974). HbS is denatured faster and differently at the air-
water interface than HbA (Elbaum et al., 1976). It has also been found that sickle red blood 
cells spontaneously generate approximately twice the normal amounts of superoxide, peroxide 
and hydroxyl radical (Hebbel et al., 1982). Spontaneous hydroxyl radical generation correlates 
significantly with the amount of membrane-bound hemichrome, suggesting that hemichrome 
iron might be directly responsible for hydroxyl radical generation through a Haber-Weiss 
mechanism, and radicals generated in the membrane would be relatively sequestered from the 
cell's antioxidant mechanism which are largely cytoplasmic (Hebbel and Miller, 1984). Excess 
heme was found in sickle erythrocyte inside-out membranes (Kuross et al, 1988). The amount 
of hemin is higher in sickle cell membranes than in normal membranes (Shaklai et al., 1985). 
The hemin content in the hemolysate of fresh red cells from patients with sickle cell disease 
is increased three- to five-fold as compared with normal individuals (Liu et al., 1988). 
Recently several articles reported the studies of the effects of heme on red cell membrane 
properties (Vincent, 1989; Chiu & Lubin, 1989 and Hebbel & Eaton, 1989). It has been shown 
that the stability of the heme in Hb follows the order (less stable to more stable): oxidized 
sickle hemoglobin (with the heme iron in the +3 oxidation state) (metHbS), oxygenated sickle 
hemoglobin (oxyHbS) and oxygenated normal hemoglobin (oxyHbA), with rate constants of 
2 
the heme transfer from these species being 0.923 h-1, 0.023 h-1 and 0.014 h-1, respectively 
(Rebbel et al., 1988). Thus work done in the last few years has clearly demonstrated that 
excessive oxidation and denaturation of sickle hemoglobin resulting in a larger amount of 
radicals in sickle red blood cells, lead to membrane oxidation and subsequently to serious 
damage to the functions of cell membranes in sickle cells. It has been suggested that RbS 
autoxidation might underlie the development of defective membrane properties in sickle cells. 
In a brief report, the autoxidation of RbS was shown to be accelerated when compared 
to RbA (Rebbel et al., 1988). It is not clear whether the accelerated RbS oxidation or the 
increased instability in RbS plays the significant role in cell oxidation. Therefore, systematic 
studies of Rb stability, Rb autoxidation and Rb oxidation in the presence of membrane 
components using controlled conditions are warranted. Due to experimental difficulties, little 
work had been done on Rb oxidation in the presence of membrane phospholipids. In fact, 
we developed a method to monitor Rb oxidation in the presence of lipid vesicles (LaBrake & 
Fung, 1992; Appendix I). In this dissertation, we present the quantitative effect of bovine 
brain phosphatidylserine (BPS), in the form of small and large unilamellar vesicles (SUV s and 
LUVs, respectively), on the oxidation of oxyRbS and interactions between Rb and lipid 
vesicles. 
We have found that the oxidation of oxyRbS is enhanced by one order of magnitude 
in the presence of LUVs and by two orders of magnitude in the presence of SUVs, and the 
enhanced oxidation is slightly greater for RbS than for RbA. 
We also found that vesicle fusion occurred in vesicle-Rb samples incubated at 37 °C, 
which was in good agreement with the literature (Szebeni, et al., 1988). Our results show that 
the fusion is about 2 times greater in the presence of RbS than RbA, for both SUVs and 
LUVs. We have used this Rb-induced vesicle fusion to investigate the mechanism of the 
interaction of RbS with BPS SUVs and LUVs, and this mechanism is compared with that of 
RbA. The interaction of Rb with phospholipid surface leads to Rb oxidation. We believe that 
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these studies are important in furthering the understanding of the pathophysiology of sickle 
cell disease. 
CHAPTER II 
MATERIALS AND METHODS 
2.1 Materials 
Unless stated otherwise, all experimental steps were carried out at 4 °C, and all 
chemicals were reagent grade from Fisher (Pittsburgh, PA), Sigma (St. Louis, MO) or Aldrich 
(Milwaukee, WI). HPLC-grade water was used for all buffers. All glassware was acid-
washed. Fresh, packed, normal red blood cells (RBCs) were obtained from a local blood bank. 
Sickle RBCs were obtained from Mt. Sinai Hospital, Chicago, IL and George Washington 
Hospital, Washington, DC. 
2.2 Hemolysate Preparation 
Hemolysate from the sickle RBCs was prepared in tandem with normal hemolysate as 
follows. The RBCs were used within one week of withdrawal and washed with 5 mM sodium 
phosphate containing 150 mM NaCl, saturated with carbon monoxide (CO), at pH 7.4. The 
cells were lysed with 2 volumes of deionized water, followed by ammonium sulphate 
precipitation and desalting with a P6DG column (BioRad, Richmond, CA), equilibrated with 
5 mM Tris buffer containing 150 mM NaCl at pH 7.5 to remove ammonium sulphate and 
other small molecules, including 2,3-bisphosphoglycerate, which affects hemoglobin 
autoxidation (Mansouri & Winterhalter, 1974; Kikugawa et al., 1981), to give stripped 
hemolysate. The hemolysate solution was dialyzed against 23 mM sodium phosphate buff er 
with 2 mM EDTA and 127 mM NaCl at pH 7.4 (PEN7.4), saturated with CO. If not used 
4 
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immediately, the hemolysate was frozen drop-wise in liquid N 2 and stored at - 80 °C. After 
thawing, the hemolysate was centrifuged at 38,000 g for 10 min before use. 
2.3 Hemoglobin Preparation 
HbS was isolated from the stripped hemolysate solution, in tandem with HbA, 
according to a modified column chromatography procedure (Kawanishi and Caughey, 1985; 
Watkins et al., 1985; Winterbourn, 1985a). The stripped hemolysates were dialyzed in 50 mM 
Tris buffer with 0.1 mM EDTA at pH 8.3 (TE8.3), followed by CO gassing. A DEAE-
Sephadex A-50 (Pharmacia, Piscataway, NJ) column was used with a linear pH gradient made 
from buffer TE8.3 and a similar buffer at pH 7.0. The HbS fractions eluted at pH 7.90 and 
the HbA eluted at pH 7 .75. The HbS and HbA fractions were pooled, concentrated, dialyzed 
against PEN7.4, and CO gassed to give carbon-monoxy Hb (COHb). This procedure removed 
all minor hemoglobin components, catalase, superoxide dismutase, "adventitious" metals, and 
other red cell proteins to give "ultra-pure" Hb (Watkins et al., 1985; Winterbourn, 1985a). If 
not used immediately, the Hb was frozen drop-wise in liquid N 2 and stored at -80 °C. 
2.4 Hb Concentration 
The total Hb concentrations in the hemolysate and Hb solutions were determined by 
the cyano-met method (Riggs, 1981). In addition, at the beginning of each oxidation 
experiment, the concentration of the oxygenated Hb (oxyHb) solution was determined at 
577 nm, using an extinction coefficient of 15.0 mM-1 cm-1 (Winterbourn, 1985a). No 
detectable absorbance at 630 nm, and thus no metHb, was observed. The concentrations of 
oxyHb generally agreed to within 5 % with the values determined by the cyano-met method. 
2.5 Lipid Vesicles 
Bovine brain phosphatidylserine (BPS) was purchased from A van ti Polar Lipids 
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(Alabaster, AL) and was used without further purification after verification of purity by 
thin-layer chromatography. Chloroform in lipid was driven off using N 2 gas followed by 
pumping under vacuum to remove residual quantities. If necessary, the lipid films were 
stored, but no longer than 48 h, at -20 °C under a N 2 atmosphere. PEN7.4 buffer solution was 
saturated with N 2 gas, and added to the lipid film. The solution was hand-swirled in the 
presence of glass beads to give multilamellar vesicles. For samples containing butylated 
hydroxytoluene (BHT), 0.5 to 1.5 mM BHT was added to the original lipid-chloroform 
solution. 
2.6 Small Unilamellar Vesicles 
Small unilamellar vesicles (SUVs) were prepared from the multilamellar vesicles by 
slightly modified procedures of Itabe and coworkers (1988). Multilamellar vesicles, with 
about 13 - 15 mg of BPS in 5 ml PEN7.4, were sonicated using a probe tip sonicator (Heat 
Systems- Ultrasonics Model W-10), to clearness under N 2 at room temperature for about 
20 min, and centrifuged at 38,000 g and 20 °C to remove any large multilamellar vesicles and 
titanium from the sonicator probe. Sonication conditions were precisely controlled to obtain 
consistent SUV samples. Otherwise, irreproducible, but generally much faster, oxidation was 
observed. The SUV samples were used immediately for oxidation studies. Lipid 
concentrations in these samples were about 2.5 mg/ml, the maximum concentration used for 
oxidation experiments. At lipid concentrations higher than 2.5 mg/ml, samples remained 
cloudy after sonication. For studies involving different lipid concentrations, the vesicle 
samples were prepared either by using different starting lipid concentrations, or by diluting 
a stock SUV solution at about 2.5 mg/ml with buffer to obtain samples of different lipid 
concentrations. Freeze fracture electron micrographs of these SUVs showed typical SUVs 
with vesicle diameters ranging from 10 - 30 nm (LaBrake and Fung, 1992). Some larger 
vesicles were also seen. 
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2.7 Large Unilamellar Vesicles 
Large unilamellar vesicles (LUVs) were prepared from the multilamellar vesicle 
solutions (13 mg to 60 mg lipid per 5 ml buffer) by extrusion methods with a lipid extruder 
(Lipex) (Loughrey et al., 1990) at room temperature. Polycarbonate filters (Nuclepore, 
Pleasanton, CA) with 50 or 100 nm pore sizes were used. Freeze fracture electron micrographs 
showed the expected BPS LUVs in solution with vesicle diameters of about 100 nm (LaBrake 
and Fung, 1992) indicating that these vesicles are much larger than SUVs. 
2.8 Lipid Concentration 
Lipid concentrations of the vesicle samples were determined by the method of Stewart 
(1980), following extraction from the aqueous phase (Bligh and Dyer, 1959). An extinction 
coefficient of 1.99 mg-1 cm-1 for BPS was obtained experimentally, in good agreement with 
the published value (Stewart, 1980). 
2.9 Optical Measurements of Hb and Vesicle Mixtures 
COHb was converted to oxyHb on ice under a flood light and 0 2 atmosphere immedi-
ately before the experiment. Optical spectra were monitored from 500 to 700 nm to insure 
complete conversion, and to insure that there was no detectable metHb in the samples. 
Samples with detectable metHb were discarded. The concentration of Hb was adjusted to 17 .5 
± 0.3 µM (1.12 ± 0.02 mg/ml). This cold oxyHb solution (120 µl) was introduced to a pre-
warmed (37 ± 0.5 °C for about 5 min) solution of lipid vesicles (500 µl) of known 
concentration in the range from 0.4 to 2.5 mg/ml, to give a final Hb concentration of 0.22 ± 
0.02 mg/ml (3.4 ± 0.3 µM). A vesicle solution with the same lipid concentration was used as 
a blank. The sample cuvettes were covered with parafilm, and maintained at 37 ± 0.5 °C. 
Spectra were collected from 500 to 700 nm every 2 min for 30 min. In experiments without 
lipid vesicles, buff er was used as a blank, and spectra were collected every 10 min for the first 
hour, and then periodically for 24 - 130 hours, if necessary. In some experiments, COHb or 
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oxygenated hemolysate was used instead of oxyHb. 
2.10 Lipid to Hemoglobin Molar Ratios 
The lipid to hemoglobin molar ratio's (Lipid/Hb) were calculated using a molecular 
weight of 64,000 for Hb and 800 for BPS. The ratios ranged from 200 to 1000 for the SUV 
experiments and 200 to 6000 for the LUY experiments. 
2.11 Concentrations of Hb Species during Oxidation 
In oxidized samples, oxyHb is oxidized to metHb, hemichrome, and choleglobin, 
following the definitions of Winterbourn (1985b ). Thus the absorbance values at different 
wavelengths can be analyzed as a four-component (oxyHb, metHb, hemichrome and 
choleglobin) system at 560,577, 630 and 700 nm, to determine the concentrations of each Hb 
species in oxidized samples (Winterbourn, 1985a). The concentration of a component was set 
to zero if the analysis gave a negative value. The relative concentrations (percentages) for 
each component were then determined. 
2.12 Rate Constant Determination 
Rate constants for the disappearance of oxyHb or the appearance of oxidized Hb were 
obtained from linear regressions (Systat Software, Systat Inc., Evanston, IL) of the linear 
portions of the logarithmic plots of percent Hb versus time. 
2.13 Vesicle Fusion Assay 
Purified Hb was mixed with SUVs or LUVs in the same lipid-to-Hb molar ratios used 
for the oxidation experiments (ranging from 500 - 1000). The samples were allowed to 
incubate at 37 °C for up to 20 hours. The absorbance at 700 nm (A700) was measured 
periodically. An increase in A700 is used as an index to measure vesicle fusion. At the Hb 
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concentrations used for this study the maximum absorbance of oxidized Hb at 700 nm is 0.01 
(LaBrake and Fung, 1992). Therefore, the absorbance above 0.01 is attributed to vesicle 
fusion. 
For fusion studies under 0 2 conditions, the initial state of the Hb is oxyHb. However, 
through the course of incubation the oxyHb was oxidized to metHb, hemichrome and 
choleglobin. Therefore, the Hb in the sample is actually a mixture of oxyHb and its oxidation 
products. 
For fusion studies under CO conditions, special care as described below, had to be 
taken to maintain the CO-Hb ligation. The HbCO samples were added to vesicle dispersions 
in buffer which had been presaturated with CO gas. The mixture was incubated at 37 °C 
under an atmosphere of CO gas in test tubes which were sealed with a rubber septum. Each 
time the test tubes were opened to remove a sample for a reading, the atmosphere was re-
equilibrated with CO gas. In this way, the Hb was maintained in the CO state. However, if 
the atmosphere was not kept under CO conditions and the vesicle dispersion was not purged 
with CO gas, the HbCO would oxidize to MetHb and hemichrome, thus complicating the 
experimental condition. The extent of CO saturation was monitored by the visible spectrum 
of Hb from 700 - 500 nm. 
2.14 Analysis of Fusion Data 
The amount of fusion in a given sample was analyzed by plotting the A700 versus time. 
Using the Systat linear regression program, it was found that the initial portion of the data 
( up to 3 hours) was a straight line. The slope of the line was determined and used as a 
measurement of the vesicle fusion per unit time. 
CHAPTER III 
RESULTS 
3.1 Autoxidation of HbS 
The autoxidation of HbS was studied using HbA as a control. The pseudo first 
order rate constants of Hb autoxidation were obtained from a fit of the linear portion of the 
semilogarithmic plot of % oxyHb versus time. The rate constants of the autoxidation in 
buffers with either 23 mM NaP04, 127 mM NaCl, 2 mM EDTA, at pH 7.4 (PEN7.4) or 100 
mM NaPO4, at pH 7.2 (P7.2) were obtained at 37 °C. In PEN7.4 HbS exhibits an average 
autoxidation of 0.030 ± 0.004 h-1 (n = 4), compared to 0.025 ± 0.003 h-1 for HbA. The ratio 
of the paired rate constants of HbS and HbA was 1.2 ± 0.1 (n = 4). Thus HbS autoxidizes 
about 1.2 times faster than HbA in PEN7.4. A paired Students t-test of the data indicates that 
the difference is statistically significant with 0.025 < P < 0.01. 
Our rate constants in P7.2, a buffer similar to that used in the literature (Hebbel et al., 
1988) were 0.053 ± 0.019 h-1 (n = 4) for HbA and 0.046 ± 0.012 h-1 for HbS. Our standard 
deviations of the rate constants in the absence of EDT A were much greater than the standard 
deviations for those rate constants obtained in the presence of EDT A. Due to the large 
fluctuations in the rate constants, we consider the data obtained in P7.2 to be not as reliable 
as those in PEN7.4. Therefore, the remainder of the oxidation experiments in the presence 
of vesicles were carried out in solution which contained EDT A. 
10 
11 
3.2 Quantitation of Oxidized Hb Species in the Presence of Vesicles 
The amounts of the four Hb species, oxyHb, metHb, hemichrome and choleglobin 
were determined as a function of time for HbS in the presence of SUVs and LUVs at a 
lipid/Rb ratio of about 800, using HbA as a control. Initial pseudo first order rate constants 
for the formation of these four species were calculated for the HbS-SUV samples as 3.98 ± 
0.42 (n = 4), 1.55 ± 0.13, I.IO ± 0.38 and 0.39 ± 0.16, respectively. The ratios of the rate 
constants for HbS samples to those for the paired HbA samples were 1.2 ± 0.1, I. I ± 0.1, 1.0 
± 0.4 and 1.4 ± 1.2, respectively (Table 1 ). 
The average pseudo first order rate constants for the four species were also calculated 
for HbS-LUV samples and were 0.38 ± 0.08 (n = 7), 0.15 ± 0.02, 0.07 ± 0.03 and 0.03 ± 0.02, 
respectively. The ratios of the rate constants for HbS samples to those for the paired HbA 
samples were I .4 ± 0.3, 1.4 ± 0.3, 1.4 ± 0.6 and 0.6 ± 0.3, respectively (Table I). 
The rate constants were further analyzed using the paired Students t-test, to determine 
the significance of the differences of the rate constants for each component. The results are 
reported in Table I under the corresponding ratios, showing the significance of the difference 
between HbS and HbA. Only paired experiments in which the Lipid/Rb ratios were closely 
matched were used for the paired Students t-test and for the rate constant ratio calculation. 
The HbS data are considered significantly different from the HbA data if the confidence level 
is equal to or greater than 95 % (P < 0.05). The l .4 and 1.2 fold differences between HbS and 
HbA in LUVs and SUVs, respectively, for the disappearance of oxyHb are both considered 
statistically significant. However, the difference in formation of metHb and hemichrome are 
only considered significant in the case of LUVs. The other rate constants for the formation 
of metHb, hemichrome and choleglobin in the presence of SUVs and the formation of 
choleglobin in the presence of LUVs are not considered significantly different as determined 
by the paired Students t-test and the ratios are presented in parenthesis (Table I). 
Table I 
Hb + LUVs 
Hb + SUVs 
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Rate Constant Ratios [k(HbS)/k(HbA)t for the Oxidation of Hb in the 
Presence of BPS SUVs and LUVs 
oxyHb 
1.4 ± 0.3 
.0l<P<.025 
1.2 ± 0.1 
metHb 
1.4 ± 0.2 
.000 I <P<.0005 
(1.1 ± 0.l)b 
.05<P<.l 
hemichrome 
1.4 ± 0.5 
.025<P<.05 
(1.0 ± 0.4)b 
.5<P 
choleglobin 
(0.6 ± 0.3)b 
.5<P 
(1.4 ± l.2)b 
.5<P 
a Rate constants were determined for lib-vesicle systems with a lipid/Hb of - 800, in 
PEN7.4 at 37 °C. 
b The rate constant ratio does not reflect a significant difference in rate constants of 
HbS and HbA since P > 0.05. 
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3.3 Lipid Concentration Effect on the Oxidation of HbS 
Figure 1 is a plot of the rate constants of HbS and HbA in the presence of BPS SUVs 
and LUVs versus Lipid/Hb. A linear regression fit of the data reveals a slight difference 
between the oxidation behavior of the sickle and normal Hbs in the presence of both SUVs 
and LUVs. The dependency of oxyHb oxidation on Lipid/Hb ratio for Hb in the presence 
of SUVs can be quantitated as follows: 
ko SUV (HbS) = 4.4 x 10-3 x Lipid/Hb + ko auto 
k
0
suv (HbA) = 3.7 x 10-3 x Lipid/Hb + k/uto 
Where k
0 
suv (HbS), k0 suv (HbA), and k/uto are the initial rate constants for HbS in the 
presence of SUVs, HbA in the presence of SUVs and autoxidation, respectively. The ratio 
of the slopes of HbS and HbA data is 1.2. A similar relationship can be written for the oxyHb 
oxidation in the presence of LUVs: 
k
0 
LUY (HbS) = 0.21 x 10-3 x Lipid/Hb + k
0 
auto 
k
0 
LUY (HbA) = 0.18 X 10-3 X Lipid/Hb + k
0 
auto 
Where k0 LUV (HbS) and k0 LUV (HbA) are the initial rate constants in the presence of LUVs 
for HbS and HbA, respectively. The ratio of the slopes is again 1.2. Thus the order of the 
rate constants of oxyHb oxidation is: 
HbS + SUVs > HbA + SUVs > HbS + LUVs > HbA + LUVs > HbS > HbA 
3.4 Physical Significance of A700 Measurement 
Generally, the intensity of scattered light is a function of particle size, as well as 
particle concentration. In our samples the lipid concentration is constant, and the vesicle 
concentration decreases as the vesicle size increases. Thus increased scattering is likely to be 
due to the formation of larger vesicles. The theoretical relationship between absorbance at 
700 nm and size or amount of fused vesicles is not delineated at this time. We are using the 
increase in A700 per unit time as an index of vesicle fusion. 
Figure I 
14 
Rate constant of Hb oxidation versus Lipid/Hb ratio. Pseudo first-order rate 
constants for the disappearance of oxyHbS (filled symbols) or oxyHbA (open 
symbols) in the presence of BPS SUVs (O ) or LUVs ( □ 100 nm, ◊ 50 nm, 
◊ 30 nm) versus Lipid/Rb in PEN7.4 buffer. The lines are linear fits through 
each data type (HbS + SUVs, HbA + SUVs, HbS + LUVs, HbA + LUVs). 
,-_ 5 ,----~------
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3.5 Vesicle fusion in the Presence of HbS 
We have shown that both SUVs and LUVs fuse when incubated with oxyHb at 37 °C 
(LaBrake and Fung, 1992). Figure 2 is a plot of average A700 (n = 6) for samples of SUVs 
(lipid concentration of 2.2 mg/ml) incubated with HbS (0.2 mg/ml) versus time. HbA was 
used as a control. The error bars are the standard deviations of the absorbance. The 
absorbance values for the HbS samples were always greater than the control HbA samples. 
The fusions were relatively rapid during the first 5 hours for both HbA and HbS, then it 
leveled off after about IO hours, to absorbance values of about 0.11 for HbS and 0.09 for HbA 
at about 20 hours. 
Figure 3 is for the samples containing LUVs (n = 4). Lipid and Hb concentrations 
were similar to the SUV samples discussed above. The A700 also increased as a function of 
time similar to those in the SUV samples, with A700 reaching 0.09 for HbS and 0.08 for HbA 
at about 20 h. During the first 5 hours, the absorbance values of LUY samples lagged behind 
those for the SUV samples. 
The absorbance data obtained during the first 3 hours in the SUV and LUY samples 
were further analyzed, compared and shown on an expanded scale in Figure 4. The 
absorbance values for all four systems (HbS-SUV, HbA-SUV, HbS-LUV and HbA-LUV) 
exhibit excellent linear time dependence, with the slopes of 17.3 x 10-3, 8.5 x 10-3, 6.7 x 
10-3 , and 3.9 x 10-3 A700*h-1, respectively, for the four systems (Table 2). Thus the vesicle 
fusion followed the order of: HbS + SUVs > HbA + SUVs > HbS + LUVs > HbA + LUVs. 
The ratios of these fusion indices for HbS and HbA were calculated as 2.0 for SUVs and 1.7 
for LUVs (Table 2). Thus, for both the SUV and LUY systems, the fusion induced by HbS 
are about 2 times greater than the fusion induced by HbA. 
The roles of Hb with different oxidation states in the fusion process were investigated 
in paired experiments (same SUV stock sample, different Hb conditions) by monitoring the 
fusion under CO conditions using purified HbCO and under 0 2 conditions using hemolysate 
Figure 2 
17 
Plot of absorbance at 700 nm of BPS SUVs in the presence of HbS (e ) and 
HbA ( 0 ) incubated at 37 °C versus time. The vesicles were prepared by 
sonication with a lipid concentration of 2.2 mg/ml and a Hb concentration of 
0.2 mg/ml and a Hb concentration of 0.2 mg/ml. Average data, from 6 
experiments, are plotted. Error bars are the standard deviation of the average. 
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Plot of absorbance at 700 nm of BPS LUVs in the presence of HbS ( □ ) and 
HbA ( □ ) incubated at 37 °C versus time. The vesicles were prepared by 
extrusion through a 50 nm polycarbonate filter with a lipid concentration of 
2.2 mg/ml and a Hb concentration of 0.2 mg/ml. Average data, from 6 
experiments, are plotted. Error bars are the standard deviation of the average. 
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Replot of absorbance at 700 nm versus time for BPS SUVs and LUVs in the 
presence of HbA and HbS on an expanded scale. Data are replotted from 
figures 2 and 3 on an expanded scale. The circles are data from figure 2 and 
the squares are from figure 3. The closed symbols are with HbS and the 
shaded symbols with HbA. The initial data (up to 3 hrs incubation time) were 
fit with linear regression to obtain and index of fusion for quantitative 
measure of fusion. The slopes of the lines are HbS + SUVs, 17 .3 x l o-3; HbA 
+ SUVs, 8.5 x 10-3; HbS + LUVs, 3.9 x 10-3; HbA + LUVs, 6.7 x 10-3 _ 
0.06,---------------,...----
0.04 
0 
0 
a:--
< 
0.02 
0.0 
0 1 2 3 4 
Time (h) 
22 
23 
Table 2 Indices of Vesicle Fusion for SUVs and LUVs in the Presence of HbS and 
HbA. 
Systema 
oxyHb + SUVsc 
COHb + SUVsd 
oxyHs + SUVse 
oxyHb + LUVs 
COHB + LUVs 
Index (A700*h-1) 
HbS HbA 
17.3 X 10-3 
9.5 X 10-3 
5.5 X 10-3 
6.7 X 10-3 
3.7 X 10-3 
8.5 X 10-3 
3.9 X 10-3 
3.4 X 10-3 
3.9 X 10-3 
2.8 X 10-3 
HbS/HbA 
2.0 
2.4 
1.6 
1.7 
1.3 
a The Hb (oxy- and CO- of HbS or HbA) + vesicle (SUVs or LUVs) solutions were 
incubated at 37 °C for upto 25 hours, the rate constants were calculated for the initial 
3 hours of incubation as described in the text. 
b Ratio of indices for HbS divided by that for HbA. 
c Lipid concentration 2.2 mg/ml, Hb concentration 0.2 mg/ml. 
d Lipid concentration 2.3 mg/ml, Hb concentration 0.2 mg/ml. 
e Lipid concentration 1.2 mg/ml, Hb concentration 0.2 mg/ml. 
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for comparison with those under 0 2 condition using purified oxyHb. The samples containing 
suVs with a lipid concentration of 2.3 mg/ml were incubated with purified Hb (COHbS, 
cOHbA) at 0.2 mg/ml concentration. The absorbance values of the systems were monitored 
for 10 hours and are shown in figure 5. The absorbance values for the CO samples with HbS 
were again larger than those with HbA, similar to the 0 2 samples, shown in Figure 2. 
Although, there is significant fusion under CO conditions, the fusion for the CO samples was 
generally less than the 0 2 samples, for both HbS and HbA. For example, the A700 value at 
8 hours for HbS was 0.078 for CO samples and 0.093 for 0 2 samples, and for HbA was 0.039 
for CO samples and 0.055 for 0 2 samples. The fusion indices for the CO data were calculated 
similar to those shown in Figure 4. Again the slope for the COHbS (9.5 x 10-3 A700*h-1) was 
about 2 times greater than that for COHbA (3.9 x10-3 A700 *h-1) (Table 2). In addition, the 
slope for the COHb-SUV was about 2 times slower than that for the oxyHb-SUV, for both 
HbS and HbA. 
Fusion data for LUVs under CO conditions were also collected similar to those for the 
SUV system and are shown in figure 6. The lipid and Hb concentrations of these LUY 
samples were similar to those used for the SUV samples. The absorbance values of the LUY 
samples were generally smaller than those of SUV samples at similar time periods during the 
first three hours. However, the fusion in the COHbS sample remained higher than the 
COHbA sample, with fusion indices as 3.7 x 10-3 A700*h-1 for COHbS and 2.8 x 10-
3 
A700*h-1 for COHbA (Table 2). 
For hemolysate samples, SUVs (1.2 mg/ml) were incubated in the presence of HbS or 
HbA hemolysates (0.2 mg/ml) under 0 2 conditions. The fusion indices were 5.5 x 10-3 
A700 *h-1 for HbS and 3.4 x 10-3 A700 *h-
1 for the HbA, which were more similar to the pure 
Hb under CO condition (9.5 x 10-3 A700*h-1 and 3.9 x 10-3 A700*h-1, respectively) than to 
the pure Hb under 0 2 condition (17 .3 x 10-3 A700 *h-1 and 8.5 x 10-3 A700 *h-1, respectively) 
(Table 2). 
Figure 5 
25 
Plot of absorbance at 700 nm of BPS SUVs in the presence of oxy- and COHb 
incubated at 37 °C versus time. HbS (filled symbols) or HbA (shaded symbols) 
at 0.2 mg/ml were incubated at 37 °C in the presence of BPS SUVs (2.3 mg/ml) 
under 0 2 ( 0 ) or CO ( ◊ ) conditions. 
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Plot of absorbance at 700 nm of BPS SUVs in the presence of oxy- and COHb 
incubated at 37 °C versus time. HbS (filled symbols) or HbA (shaded symbols) 
at 0.2 mg/ml were incubated at 37 °C in the presence of BPS LUVs (2.3 
mg/ml) under 0 2 ( D ) or CO ( ◊ ) conditions. 
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CHAPTER IV 
DISCUSSION 
4.1 Oxidation of HbS in the Presence and Absence of Vesicles 
The initial pseudo first order rate constant for the autoxidation of HbS in PEN7.4, 
a buffer containing EDTA, at 37 °C was determined to be 0.030 ± 0.004 h-1 (n = 4) which was 
larger than that for HbA (0.025 ± .003 h-1). The 1.2 ± 0.1 fold increase in autoxidation of 
HbS over that of HbA was shown to be statistically significant. These values are generally in 
agreement with those presented in a brief report (Hebbel et al., 1988), in which a solution of 
HbS was shown to autoxidize with a rate constant 0.050 h-1, in P7 .2, without EDT A, and HbA 
with a rate constant of 0.029 h-1. Their ratio of the rate constants is higher than ours. 
However, no standard deviations were given for their rate constants. The same authors later 
reported that the autoxidation rates of HbS varied somewhat (Hebbel, 1990), presumably 
from run to run. We found that the rate of autoxidation in the absence of EDT A was more 
variable, and thus less reliable, than those in the presence of EDT A. Similar findings that, 
in the absence of EDT A, the rate of autoxidation was substantially faster and quite variable 
were reported. (Winterbourn, 1976, Antonini and Brunori, 1971). Thus the determination of 
the rate constant of autoxidation is more reliable when measured in the presence of EDT A 
than in the absence of EDT A. In our hands, we are unable to conclude whether the 
autoxidation for HbS is faster or slower than HbA in buff er without EDT A. However, in the 
presence of EDT A, as stated above, HbS autoxidizes about 1.2 times faster than HbA. 
Although it is not clear how the HbS mutation causes enhanced autoxidation, two 
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suggestions have appeared in the literature: 1) due to the innate instability of the HbS 
molecule (Hebbel, 1990), or 2) due to an altered folding/unfolding equilibrium at the N-
terminal end of the /36 position (personal communication between Perutz and Hebbel and cited 
by Hebbel, 1990). Whatever the causes may be, the enhanced autoxidation has been suggested 
to underlie the membrane damage and hemolysis in sickle cells. 
Since Hb oxidation is enhanced by lipid vesicles (LaBrake and Fung, 1992), an 
understanding of HbS oxidation in the presence of lipid vesicles is crucial. We chose BPS as 
the lipid for preparing vesicles because PS is one of the major phospholipid components found 
in the inner leaflet of the erythrocyte membrane bilayer (Marinetti and Crain, 1978). We 
quantitatively determined the rate constants of the disappearance of oxyHb, and the 
appearance of metHb, hemichrome and choleglobin for HbS in the presence of SUVs and 
LUVs. We found that the rate constant for the disappearance of oxyHbS was enhanced one 
order of magnitude in the presence of LUVs and two orders of magnitude in the presence of 
SUVs, similar to those results obtained for HbA (LaBrake and Fung, 1992). In our earlier 
studies, we have shown that the difference in the rate constants between SUVs and LUVs 
could not be attributed to lipid peroxidation products or artifacts due to the sonication or 
extrusion processes used in sample preparations, but rather to the different surface energy of 
the bilayer surface. We have now found that HbS oxidation in the presence of the 
phospholipid surface is also greatly enhanced. In paired experiments, the ratio of the rate 
constants of HbS over HbA for the disappearance of oxyHb in the presence of LUVs was 1.4 
and of SUVs was 1.2. These ratios were very similar to the 1.2 fold increase in autoxidation. 
There does not appear to be an antagonistic or synergistic effect on HbS oxidation due to the 
SUVs or LUVs. 
4.2 HbS enhanced Fusion of SUVs and LUVs 
Lipid fusion in model membranes can be induced by many different fusogens (species 
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which promote fusion). The fusion event is preceded by dehydration at the point of close 
contact between two membranes. This is followed by packing defects among lipid molecules 
which leads to hydrophobic contact and thus initiation of fusion (Papahadjopoulos, 199 I). 
Understanding the mechanism of Hb induced fusion will help to explain the mechanism of 
the interaction of Hb with a phospholipid surface and further the understanding of the 
pathological difference between HbS and HbA. 
We monitored the fusion of SUVs and LUVs in the presence of HbS and HbA under 
0 2 and CO conditions. Hb-induced SUV fusion per unit time was a factor of two larger than 
that for the Hb-induced LUY fusion. This observation was independent of the Hb system 
studied and is explained by the increased surface tension associated with the SUVs. It has 
been shown that, under the same fusion promoting conditions, SUVs fuse more rapidly than 
LUVs (Ohki, 1984). 
Since the behavior of lipid fusion between the LUVs and SUVs was similar for each 
Hb system (HbS and HbA under 0 2 and CO conditions), only the data associated with SUVs 
in different Hb systems will be discussed. 
HbS promoted more fusion compared to HbA under CO conditions, where no Hb 
oxidation was detected. Fusion induced by hemolysate, which has little detectable Hb 
oxidation due to the antioxidants in the hemolysate, was similar to fusion induced by COHb. 
Although the HbS and HbA molecules are isomorphous at crystallographic resolution 
(Hebbel, 1990), subtle conformational differences do exist which may, in part, explain the 
fusion phenomenon. First, during mechanical agitation of Hb solutions, oxyHbS or COHbS 
precipitate faster than oxyHbA or COHbA, suggesting a conformational difference between 
HbS and HbA when ligated in the Fe+2 oxidation state (Asakura et al., 1973). Surface 
conformational differences between HbS and HbA were also detected by NMR (Fung et al., 
1975). In addition, HbS was found to unfold to a greater extent than HbA at the air water 
interface, and this difference in surface activity may be due to destabilization of hydrophobic 
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interactions on the hydrophobic surface (air) (Elbaum et al., 1976). 
The fusogenic behavior of the Rb molecule itself is not well understood. In another 
study of Rb vesicle interaction, when RbA was incubated for 15 h with SUVs, only 11-18 % 
of the total heme cosedimented with lipid vesicles (Szebini et al., 1988), indicating the Rb 
molecule is not adhering with a high affinity to the lipid surface. It is possible that the weak 
Rb-lipid interaction causes increased surface hydrophobicity in lipid vesicles, initiating 
fusion. Our results demonstrate different surface activities between RbS and RbA to cause 
increased vesicle fusion of RbS compared to RbA under CO conditions. 
The results of Rb under 0 2 conditions promoting more vesicle fusion than Rb under 
CO conditions and hemolysate under 0 2 conditions suggest that products of Rb oxidation 
further promote vesicle fusion, in good agreement with the results showing vesicles fuse more 
rapidly in the presence of metRb as compared to oxyRb (Szebeni et al., 1988). In addition, 
lipid peroxidation products are expected to be present in the later stages of Rb-vesicle 
incubation (> l h) (Itabe et al., 1988). The presence of lipid peroxidation products such as 
lipid hydroperoxides of the fatty acid components of phospholipids, cyclic peroxides and 
epoxides, are known to promote vesicle fusion (Gast et al., 1982). This is not so for the CORb 
system where little or no oxidation products are present even in the later stages of incubation 
(i.e. > 30 min). Therefore, the presence of metRb and other Rb oxidative products as well 
as other lipid peroxidation products are believed responsible for the much greater initial rate 
of fusion in the Rb under 0 2 conditions as compared to the Rb under CO conditions and 
hemolysate under 0 2 condition systems. 
These data support the hypothesis that there are several additive factors in the system 
contributing to the vesicle fusion. They include the type of vesicle used (SUV or LUY), the 
oxidation state and ligation of the heme in the molecule, and the surface conformation of the 
Rb molecule. 
The oxidation of RbS in the presence of vesicles is enhanced as compared to RbA. 
33 
Therefore, the differences in the HbS compared to HbA under 0 2 condition are additive 
effects of different Hb surface conformations and oxidative products. 
4.3 Summary 
The known differences between oxyHbS and oxyHbA are the increased mechanical 
instability and surface activity of HbS as compared to HbA. There also appears to be a slight 
increase in autoxidation rate for HbS. The mechanism which causes the enhanced oxidation 
of Hb in the presence of vesicles has been attributed to an interaction of oxyHb with the lipid 
surface, largely due to hydrophobic interaction. This is indicated by the order of magnitude 
enhancement of oxidation due to the presence of the more curved SUVs as compared to 
LUVs. However, the difference in the initial rate of oxidation in the presence of SUVs and 
LUVs for HbS compared to HbA is no greater than the difference in autoxidation. Therefore, 
the effect of vesicle surface on Hb oxidation appeared to be similar in HbS and HbA. 
However, there is a marked difference between the amounts of vesicle fusion for the HbS as 
compared to the HbA system. This difference is also evident under CO conditions and Hb 
hemolysate under 0 2 conditions. This suggests that HbS is less stable at the lipid-water 
interface than HbA. It is likely that the excessive oxidation found in sickle red blood cells 
is due to intrinsic surface conformation difference between HbA and HbS, and not due to the 
intrinsic oxidative properties in HbA and HbS. Further studies of HbS- lipid surface 
interaction may provide molecular understanding toward pathophysiology of sickle cells. 
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PART II 
CHAPTER I 
INTRODUCTION 
Spectrin, a major protein in the human erythrocyte membrane skeleton, was first 
isolated in 1971 in the low ionic strength extract of the membrane (Clarke, 197 I; Fairbanks 
et al., 1971). The name "spectrin" was based on the fact that hemoglobin-free erythrocyte 
membranes are referred to as "ghosts" (ghost= specter) (Bennett, 1990). Its function is to play 
a role in determining the mechanical properties and maintaining the unique biconcave shape 
of the erythrocyte. Spectrin consists of two subunits, defined as a with a molecular weight 
of about 285,000 (Sahr et al., 1990) and f3 with a molecular weight of about 246,000 
(Winkelmann et al., 1990), arranged as a heterodimer with the two subunits associated side-to-
side in an anti-parallel orientation to give a flexible rod approximately 1,000 A long, as 
visualized by electron microscopy (Shotton et al., 1979). The dimers associate head-to-head 
to form tetramers. Amino acid sequence (Speicher et al, 1983) and cDNA sequence (Curtis 
et al., 1985; Winkelmann et al., 1988) analyses reveal that about 90 % of spectrin, by mass, is 
comprised of repetitive structural units of 106 amino acid residues. The dimensions of the 
106-residue segment, ~55 x 30 A, based on electron microscopy (EM) data of the intact 
spectrin (Shotton et al., 1979), are similar to the dimensions of other globular proteins. A 
simple and attractive triple helical structure has been proposed for the 106-residue segment 
(Speicher, 1983 ), and refinements of the original triple helical model have also been published 
(Dubreuil et al., 1989; Parry et al., 1992). A more detailed five-fold structure has also been 
suggested (Xu, et al., 1990). 
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Since spectrin plays a role in the dynamics of the highly flexible erythrocyte 
membrane, several studies have been used to probe the dynamic nature of the molecule. 
Saturation transfer (ST) EPR studies of spin-labeled spectrin-actin complex provided 
quantitative information on the motion of the molecule, and revealed that the spectrin-actin 
complex appears to exhibit multiple classes or rates of motion over a wide time range, from 
10-9 to 10-3 s (Fung & Johnson, 1983). Proton nuclear magnetic resonance studies suggested 
some internal motions within the spectrin molecule with about 15 % of the molecules 
exhibiting motions about 10-9 - 10-10 s at 37 °C (Fung et al., 1986), and the remaining 
motions being slower than 10-5 s (Fung et al., 1989). Transient dichroism studies reveal 
motions of about 10-4 sat 4 °C (Clague et al., 1990). Dynamic light scattering measurements 
have detected segmental motion on the order of 23 µs at 20 °C (Budzynski et al., 1992). 
Together these studies suggest multiple classes of segmental motions in spectrin molecules. 
Structural studies have also been performed on spectrin. Electric birefringence 
relaxation studies (Mikkelsen & Elgsaeter, 1978), measurements of the rotational relaxation 
time and intrinsic viscosity studies of spectrin dimers (Mikkelsen, 1984) support the 
description of spectrin as a flexible and extended molecule in solution. Light scattering 
experiments (Elgsaeter, 1978) have revealed that the radius of gyration nearly doubles upon 
decreasing the ionic strength from 100 mM NaCl to 1 mM NaCl. Circular dichroism (CD) 
data estimate the a-helix content to range from -60- 75 % (Ralston, 1978; Calvert et al., 1980), 
and secondary structure prediction programs predict the secondary structure to have 62 % a-
helix, 16 % ,8-sheet and 22 % other structural components such as random coils and turns (Xu 
et al., 1990). Due to its large molecular weight, it has been difficult to apply 
multidimensional NMR techniques to study structural components of spectrin, and since 
spectrin has not been crystallized there is no x-ray information. 
We have used Fourier transform infrared spectroscopy (FTIR) to investigate the 
secondary structure of spectrin under different ionic strength, denaturing conditions and in 
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the presence of lipid vesicles. Recent developments in infrared spectroscopy using Fourier 
transform instrumentation have eliminated the problems of low sensitivity and interfering 
absorbances by solvents such as water (Surewicz & Mantsch, 1988). IR spectroscopy is 
sensitive to the C=O stretching (1600 - 1700 cm-1, amide I) and the N - H bending (1500 -
1600 cm-1, amide II, for samples in H2O; and N-D bending at 1400 - 1500 cm-1, amide II', 
for samples in D2O) arising from the molecular bonds in the protein backbone (Cantor & 
Shimmel, 1980). Changes in the frequencies of these characteristic IR absorbances also reveal 
the strength of the H-bonding in the backbone. Thus, each type of secondary structure (a-
helix, ,a-sheet, random coil and turns) has a characteristic IR spectrum. A protein is assumed 
to be a linear combination of the above mentioned secondary structural components. Thus, 
by examining the spectrum in the amide I and II regions, one can obtain the percentage of 
secondary structural components in a protein. FTIR methods have proven superior to circular 
dichroism (CD) methods in the prediction of ,8-sheet (Sarver & Kreuger, 1991), and the 
secondary structure can also be probed under conditions of high concentration and in the 
presence of vesicles which would cause absorbance and light scattering problems in a CD 
experiment. 
In this thesis, the secondary structure of spectrin under denaturing conditions of high 
pH, SDS treatment and heat treatment was probed to determine the sensitivity of the FTIR 
technique to structural changes in spectrin. This technique was then applied to study the 
secondary structural changes under different ionic strength and in the presence of large 
unilamellar vesicles. We found that FTIR is a sensitive and reliable technique to study the 
secondary structure of spectrin. Since the overall dimension of spectrin has been shown to 
be sensitive to ionic strength (Elgsaeter, 1978), we used gel filtration chromatography to 
determine the effect of ionic strength on the Stokes radius of our spectrin sample. We have 
shown that the Stokes radius of spectrin is sensitive to changes in sodium chloride 
concentration in buffer. However, using FTIR, we found no secondary structural differences 
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in spectrin in buffers of different ionic strength. Finally, we use our experimental results to 
support a proposed model of the tertiary structure of spectrin. 
CHAPTER II 
MATERIALS AND METHODS 
2 .1 Spec tr in Preparation 
Human red blood cells (RBCs) were obtained from the local blood bank and used 
within one week of withdrawal. All steps were carried out at 4 °C unless specified otherwise. 
RBCs were washed 3 times with 5 mM sodium phosphate buffer with 150 mM NaCl at pH 8.0 
(PBS8). White membrane ghosts were prepared by lysing the washed RBCs with 20 volumes 
of 5 mM phosphate buffer at pH 8.0 (5P8) and then washing the membrane 3 times with the 
same buffer, according to the method of Dodge et al. (1963). The spectrin dimer and tetramer 
preparations were done according to published methods (Ungewickell & Gratzer, 1978; 
Budzynski et al., 1992). For spectrin dimer preparation, the membrane ghosts were washed 
once with 0.3 mM phosphate buffer at pH 7 .6 (0.3P7 .6), followed by incubation with 2-3 
volumes of 0.3P7.6 for 30 min at 37 °C. For spectrin tetramer preparation, the membrane 
ghosts were dialyzed against 0.3P7 .6 buffer overnight. After incubation at 37 °C or overnight 
dialysis, the membranous solution was centrifuged at 400,000 gin an ultracentrifuge for 20 
min. The supernatant containing the spectrin-actin complex was pooled and concentrated with 
an ultrafiltration cell (Amicon, Danvers, MA) to a concentration of about 1.5 mg/ml. The 
spectrin concentrations for the experiments were determined using an extinction coefficient 
of 1:1%280=10 (Marchesi et al., 1969; Clarke, 1971). The spectrin-actin solution was loaded 
onto a gel filtration column (Sepharose 4B-CL, Pharmacia, Piscataway, NJ) equilibrated with 
25 mM Tris, 5 mM EDTA and 100 mM NaCl at pH 7.6 and eluted at a flow rate of 22 ml/hr 
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for about 16 hours. The spectrin fractions, either dimer or tetramer, were pooled and 
concentrated (Amicon CF-25 cones) to a concentration of 5 - 10 mg/ml and dialyzed 
overnight against either PBS7.4 (same as PBS8 except at pH 7.4) or 5P7.4 (same as 5P8 except 
at pH 7.4). The spectrin was then concentrated (Amicon Centricon-30 Microconcentrators) 
to about 35 mg/ml. 
2.2 Spectrin in D20 Buffer 
Spectrin dimer sample was subjected to D20 exchange, using PBS7.4/D20 buffer 
(PBS7.4 made with 99.9 % D20, Norell, Inc, Landisville, NJ). The D 20 exchange was carried 
out by adding about 1.5 ml of the D 20 buffer to about 500 µl of the concentrated spectrin (35 
± 5 mg/ml). The solution was concentrated for about 1.5 h (Amicon Centricon-30 
Microconcentrator). The cycle was repeated 4 times. The filtrate from the last exchange was 
saved and used as the background for the FTIR measurements, to account for the residual 
HOD or H20 in the sample. The final spectrin concentration was 35 ± 5 mg/ml. 
2.3 SOS treated Spectrin 
50 µl of a 10 % sodium dodecyl sulphate (SOS) (Bio-Rad, Richmond, CA) in 
PBS7.4/H20 was added at room temperature to 450 µl of spectrin dimer (35 ± 5 mg/ml) in 
PBS7.4/H20 to give a final concentration of 1 % SOS. The mixture was allowed to equilibrate 
for about 1 hour before the FTIR measurement. A 1 % SOS solution in PBS7.4 was used as 
a blank. 
2.4 Heat denatured Spectrin 
Dilute spectrin dimer (about 5 mg/ml) in 5P7.4/H20 was heated to 80 °C for 10 min, 
then cooled to room temperature. The sample was then concentrated to 35 ± 5 mg/ml. The 
low salt 5P7.4 buffer was used because spectrin precipitated out of solution when heated in 
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high ionic strength PBS7.4. 
2.5 NaOH treated Spectrin 
Concentrated sodium hydroxide (NaOH) was added to the spectrin dimer sample (35 
± 5 mg/ml) in PBS7.4/H20) to yield a final concentration of 2 M NaOH. Buffer with 2 M 
NaOH was used as a blank. 
2.6 Spectrin and Lipid Vesicles 
Large unilamellar vesicles (LUVs) of bovine brain phosphatidylserine (BPS) were 
prepared by dispersing a film of BPS in PBS7.4/H20 (LaBrake & Fung, 1992). The dispersion 
was subjected to a freeze/thaw cycle five times by submerging the flask in liquid N2 followed 
by a 37 °C water bath, then passed through an Extruder (Lipex, Vancouver, B.C. Canada), 
equipped with two 100 nm pore size polycarbonate filters (Nuclepore, Pleasanton, CA), ten 
times at high N 2 pressure (about 250 psi) to form LUVs. The average diameter of these LUVs 
is 130 nm (LaBrake & Fung, 1992). The LUVs were mixed with the pure spectrin dimer to 
yield a final concentration of 28 mg/ml BPS LUVs and 20 mg/ml spectrin. A blank composed 
of BPS LUVs at the same concentration was used. 
2. 7 Stokes Radius 
The Stokes radius (R8 ) of spectrin under different buff er conditions was estimated 
using a gel filtration column (Sepharose 4B-CL, 81 x 1.5 cm) with a flow rate of 22 ml/h. 
The column was equilibrated with PBS7 .4. A gel filtration calibration kit (Pharmacia) 
including the proteins, hemoglobin (Rs= 31 A), bovine serum albumin (Rs= 37 A), catalase 
(R5 = 52 A), ferritin (R5 = 60 A) and thyroglobulin (R5 = 81 A) were used to calibrate the 
column. The Stokes radii of the proteins were given with the literature accompanying the 
kit. Dextran blue was used to calculate the void volume (V 0 ). The partition coefficient (Kay) 
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of each protein was calculated according to the following equation: 
Kavx = (Vex - Vo)/(Vt - Vo) 
where: V /=elution volume of protein x and Vt= total volume of the column. The values 
of Kav vs log(R8 ) are shown in Figure 1, also shown is the linear regression of the data to give 
a calibration curve. The equation of the line, log(R 8 ) = 2.52 - 1.22 x Kav• was used to 
calculate the Stokes radius of the spectrin under different conditions. 
For the elution of spectrin under different buffer conditions, the column was first 
equilibrated with the appropriate buff er. 
2.8 Infrared Spectroscopy 
Fourier transform infrared (FTIR) spectra were recorded with a Bio-Rad FTS-40 
FTIR spectrophotometer with a triglycine sulphate (TGS) detector and processed with the 
dedicated Digilab computer. Typically, 1048 interferograms were recorded at 20 °C, coadded, 
triangularly apodized and Fourier transformed to give a single beam spectrum (intensity vs. 
wavenumber) with a resolution of 2 cm-1. For the measurements of samples in H20 buffer, 
a semi-permanent cell equipped with CaF2 salt plates and a 6 µm tin spacer was used. It is 
necessary to use 6 µm spacers to insure the H20 absorbance at 1640 cm-1 is less than unity to 
permit quantitative spectral subtraction of the background (Dousseau & Pezolet, 1990). 
Although a restriction in resolution to 2 to 3 cm-1 results, an open aperture was used to allow 
maximum signal to reach the detector. For the measurements of samples in D20 buffer, a 
standard IR cell equipped with CaF2 salt plates and a 15 µm teflon spacer was used. A 2 cm-1 
aperture size was adequate for these measurements. For each spectrin sample run, a single 
Figure I 
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Plot of partition coefficient (Kav) vs log of the Stokes radius (R8 ) for a series 
of standard proteins. Points are for the standard proteins hemoglobin, bovine 
serum albumin, catalase, ferritin and thyroglobulin. The best fit least squares 
line is the calibration curve for determining the Stokes radius of spectrin. 
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beam spectrum was collected on the spectrin sample, on the buffer (background) and on a 
clean empty cell (air). 
2.9 Data Analysis 
2.9.1 Absorbance Spectra 
The absorbance spectra of the samples were calculated from the single beam intensity 
spectra by taking the log of the ratio of the single beam spectrum of the sample of spectrin 
to that of air. Similarly, the absorbance of the background referenced to air was determined. 
2.9.2 Baseline Subtraction 
To obtain the absorbance spectrum of spectrin in solution, the background absorbance 
spectrum was subtracted from the spectrin absorbance spectrum numerically with an array 
basic program (SUBH2O) (Dousseau et al., 1989), which was written for Spectra-Cale 
software (Galactic Ind., Salem, NH) and was generously provided to us by Dr. Pezolet. In 
order to use this numerical method, the spectra had to be transferred from the Digilab to the 
IBM computer and imported into the Spectra-Cale software. The algorithm for the array 
basic program was designed to multiply the background spectrum by a scaling factor (scaled 
up and down in small increments) and subtract it from the sample spectrum until the 
difference spectrum in the region of 1750 - 2650 cm-1 was flat as determined by a minimum 
chi2 for the least squares fit (Dousseau et al., 1989). The subtraction was also performed 
manually using the Digilab computer, equipped with a joy stick on the keyboard, by 
"tweaking" the scaler unit of the background spectrum with the joy stick until a flat baseline 
in the sample spectrum was obtained in the region from 2000 to 1700 cm-1. 
2.9.3 Second Derivative Spectra 
The second derivative spectra of the absorbance spectra were calculated using 
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satandard Digilab software (BIO-RAD) to provide the peak positions needed for the band 
fitting routine (see below). 
2.9.4 FSD Deconvolved Spectra 
Deconvolution of the absorbance spectrum serves to narrow the broad overlapping IR 
bands, thereby resolving the bands due to different secondary structure components. Fourier 
self-deconvolution (FSD), an algorithm which operates on the Fourier transform of the 
absorbance spectrum (Kauppinen et al., 1981 ), was used for the deconvolution. A triangular 
apodization function with a resolution enhancement parameter of K = 2.0 and full width at 
half height parameter of FWHH = 16 cm-1 was used for the spectrin in D20 spectra and 
FWHH = 14 cm-1 for the spectrin in H20 spectra. 
2.9.5 Band Fitting to the FSD Deconvolved Spectra 
The band fitting was performed on the deconvolved spectra using the Spectra-Cale 
software Curve-fit routine following the guidelines outlined by Byler and Susi (I 986). The 
initial peak positions were obtained from the second derivative spectra. A 100 % Gaussian 
band shape was assumed. The integrated area under the curve-fit bands was assumed to be 
proportional to the concentration of secondary structure responsible for that band. Band 
assignments of secondary structure components were made according to the literature (Cantor 
& Shimmel, 1980; Byler & Susi, 1986; Dong et al., 1990). 
2.9.6 Partial Least Squares Analysis 
The data for spectrin in H20 buff er were also analyzed using the partial least squares 
analysis (PLS) method as outlined before (Dousseau & Pezolet, 1990). The method can be 
easily employed by using the PLS-QUANT module in the Spectra-Cale software. A set of 14 
spectra of proteins of known secondary structure in H20 buffer (Dousseau & Pezolet, 1990) 
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(training set) was obtained from Dr. Pezolet. These protein spectra were then input into the 
PLS QUANT module of Spectra-Cale, and the calibration spectrum was calculated using a 
dimension of 25 and four components: ordered o:-helix, unordered o:-helix, ,B-sheet and other 
(includes turns and random coil). For comparison to the band fitting results, the ordered and 
unordered helix components were added together and presented as total o:-helix. 
One of the proteins from the calibration set was a 100 % o:-helix poly lysine. Since 
poly lysine is sometimes unstable at 100 % structure, the calibration spectrum was recalculated 
without this polypeptide. However, there was no significant difference in the structural 
prediction in the absence of polylysine, so this polypeptide was left in the training set. The 
spectrin spectra with the background subtracted using the SUBH2O program mentioned 
above, were normalized before being analyzed by the PLS method. The spectra were prepared 
by setting the limits of the spectra from 1480 - 1720 cm-1, adjusting a flat baseline with 2 
point baseline correction, setting the baseline to O and finally normalizing the total intensity 
to unity. Thus, using the PLS-QUANT Spectra-Cale program with our calibration spectrum, 
the secondary structure of the protein could be determined from the spectrin FTIR 
absorbance spectrum. 
CHAPTER III 
RESULTS 
3.1 Stokes Radius 
The Stokes radius of a molecule is defined as its effective hydrated radius (Cantor & 
Shimmel, 1980). The Stokes radius for spectrin has been determined from gel filtration 
chromatography (Kam, et al., 1977). We used similar methods to calculate the Stokes radius 
of spectrin dimers and tetramers in 5 mM sodium phosphate buff er at pH 7.4 with sodium 
chloride concentrations ranging from O to 150 mM (Table I). The Stokes radius of spectrin 
dimer increases from 124 A in buffer with 150 mM NaCl to 178 A in buffer without NaCl. 
The radius determined for spectrin tetramer was 250 A in buff er with I 50 mM NaCl. 
However, the radius in buffer without NaCl was not obtained because the spectrin tetramer 
eluted with the void volume, but can be estimated to be ~ 330 A, when Kav is 0. 
3.2 FTIR Spectra of Spectrin Dimer 
3.2.l Spectrin in PBS7.4/H20 Buffer 
The absorbance spectrum of spectrin dimer (35 ± 5 mg/ml) in PBS7.4/H20 is shown 
in figure 2a. The spectrum has two major bands, assigned as the amide I band (I 700 - 1600 
cm-1 region) and the amide II band (1600 - 1500 cm-1 region). The amide I band is 
symmetric and narrow, which is consistent with a protein of high a-helical content (Dousseau 
& Pezolet, 1990). 
The second derivative spectrum of the absorbance spectrum is shown in figure 2b. The 
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Table 1 
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Stokes Radii for Spectrin Dimer and Tetramer in Different Ionic Strength 
Buffers. 
Sample [NaCl] (mM) 
spectrin dimer 150 124 
spectrin dimer 100 155 
spectrin dimer 50 160 
spectrin dimer 0 178 
spectrin tetramer 150 250 
spectrin tetramer o** 
** eluted with void, unable to calculate Stokes radius 
Figure 2 
51 
FTIR absorbance, second derivative, FSD deconvolution and band fit spectra 
of spectrin in PBS7 .4/H2O. (a) Absorbance spectrum of spectrin (35 ± 
5 mg/ml) in PBS7.4/H2O buffer. (b) Second derivative spectrum of the 
absorbance spectrum in (a). (c) Deconvolved spectrum of the absorbance 
spectrum in (a) using deconvolution parameters FWHH = 14 cm-1 and K=2. 
(d) Band fit of the deconvolved spectrum from the (c). The spectrum was 
curvefit out to 1500 cm-1 to insure minimum error due to overlap between the 
Amide I and II regions. The five bands in the Amide I region yield 55 % o:-
helix, 9 % ,8-sheet and 29 % "other". 
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amide I band is comprised of 3 major bands at 1681 cm-1, 1651 cm-1 and 1631 cm-1. The 
largest peak at 1651 cm-1 is assigned to the o:-helix component (Dong et al., 1990). It has 
been reported that the second derivative bands can be assigned and used to quantitate the 
secondary structure elements by measuring the area of the peaks (Dong et al., 1990). 
However, in our case there was a large percentage of o:-helix which distorts the baseline, and 
the second derivative spectra were not a reliable method of structure quantitation. 
Figure 2c shows the FSD deconvolved spectrum corresponding to the original 
absorbance spectrum (Figure 2a). Band narrowing by the deconvolution operation allows the 
decomposition of the amide I band into its underlying components. 
Figure 2d is the best band fit to the FSD deconvolved spectrum from figure 2c. Band 
fitting allows quantitation of the bands arising from the secondary structure elements which 
are narrowed as a result of the deconvolution procedure (Byler & Susi, 1986). The spectrum 
was curvefit to 1500 cm-1 to insure minimum error due to overlap between the amide I and 
II regions. However, for quantitation of the secondary structure our attention was focused 
on the amide I region only. The analysis gave rise to 5 bands under the amide I region. The 
positions of the bands and their relative areas are shown in Table 2. The band centered at 
1651 cm-1 was assigned to o:-helix and accounted for 55 % of the integrated intensity. The 
band at 1680 cm-1 was assigned to the ,8-sheet with 9 % of the area, and the bands at 
1667 cm-1 and 1632 cm-1 were assigned to other structural components, including random 
coil and turns, to comprise the remaining 29 %. Simple analysis has assumed that the 
extinction for each secondary structural type is the same so that these percentages are 
proportional to the fraction of that secondary structure type in the protein (Byler & Susi, 
1986). 
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Table 2 Band Fitting Peaks, Assignments and Relative Areas of Amide I and I' 
Regions. 
H20 buffera 
Peak (cm-1) Assignmentb 
1680 P-sheet 
1667 otherd 
1651 a-helix 
1632 other 
1616 unsuree 
Area(%) 
9 
11 
55 
18 
7 
D20 buffer 
Peak (cm-1) Assignmentc Area(%) 
1675 P-sheet 3 
1669 P-sheet 4 
164 7 a-helix 60 
1628 other 28 
1606 unsuree 5 
a 5 mM sodium phosphate, 150 mM sodium chloride, pH 7.4 
b Assignments made from Dong et al, 1990 & Cantor and Shimmel, 1980. 
c Assignments made from Byler & Susi, 1986. 
d Other includes random coil and turns. 
e This band cannot be assigned from the literature. 
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3.2.2 Spectrin in PBS7.4/D20 Buffer 
The absorbance spectrum of spectrin (35 ± 5 mg/ml) in PBS7.4/D20 buffer is shown 
in figure 3a. The one major band is assigned as the amide I' band, which is similar to the 
amide I band except all absorbances are shifted to lower energy due to the increased mass of 
the deuterium (2H) atom. The amide 11' band (1500 - 1400 cm-1, not shown) was not 
analyzed due to HOD absorbance interfering with the protein absorbance in this region. The 
low broad band between 1600 cm-1 and 1500 cm-1 is assigned to the glutamate and aspartate 
absorbances (Venyaminov & Kalnin, 1990). Spectrin is comprised of 10 mole% aspartic acid 
and 18 mole% glutamic acid (Sahr et al., 1990; Winkelmann et al., 1990). 
The second derivative spectrum is shown in figure 3b. Three major peaks are 
evident at 1677 cm-1, 1648 cm-1 and 1602 cm-1. In addition, there is a shoulder at 1629 cm-1 
on the 1648 cm-1 peak. The largest peak in the amide I' region at 1648 cm-1 is assigned to 
a-helix. 
The FSD deconvolution spectrum of the absorbance spectrum is shown in figure 3c. 
The most striking feature is that the amide I' band is much broader than the amide I band. 
A possible explanation for the amide I' band being broader is that the absorption which arises 
from the random coil element in the D20 sample is shifted more to a lower energy than are 
the transitions arising from the a-helix (Prestrelski, 1992; personal communication). 
Figure 3d is the best band fit to the deconvolution spectrum from figure 3c. The 
amide I' band was used for the quantitation of secondary structure. However, the bands were 
fit out to the 1500 cm-1 for the same reason as with the H20 spectrum. The spectrum has 5 
bands under the amide I' region. The prominent band at 1647 cm-1 is assigned to the a-helix, 
which accounts for 60 % of the secondary structure. The ,B-sheet assignments were more 
Figure 3 
56 
FTIR absorbance, second derivative, FSD deconvolution and band fit spectra 
of spectrin in PBS7.4/D2O. (a) Absorbance spectrum of spectrin 
(35 ± 5 mg/ml) in PBS7.4/D2O buffer. (b) Second derivative spectrum of the 
absorbance spectrum in (a). (c) Deconvolved spectrum of the absorbance 
spectrum in (a) using deconvolution parameters FWHH = 16 cm-1 and K=2. 
(d) Band fit of the deconvolved spectrum from (c). The spectrin was fit out 
to 1500 cm-1 for the same reason as in Figure 2d. The five bands in the Amide 
I' region yield 64 % a-helix, 7 % ,8-sheet, and 28 % "other". 
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difficult to assign in this spectrum. They were assigned as 1675 cm-1 (3 %) and 1669 cm-1 
(4 %) for a total of 7 %. The assignment of the 1606 cm-1 band is questionable. The band 
at 1628 cm-1 is assigned with confidence to other, which accounts for the remaining 28 %. 
A summary of the assignments is given in Table 2. 
3.2.3 PLS Analysis 
Although band fitting provides a basis for the quantitative estimation of the secondary 
structure of proteins, it is not a routine procedure since there are still difficulties with 
obtaining artifact free resolution enhanced spectra and with the band fitting procedure 
(Dousseau and Pezolet, 1990). And more importantly the band assignments are a problem due 
to their non uniqueness and partial deuteration of the sample. Therefore, another more robust 
technique using the partial least squares (PLS) method of spectral analysis was employed. We 
used a training set of spectra from 14 proteins of known secondary structure in H20 buffer, 
recently published (Dousseau & Pezolet, 1990), to calculate a calibration spectrum for the PLS 
analysis. A similar quality training set of spectra for proteins in D20 buff er was not available 
to us, therefore, only spectra recorded in H20 buff er were analyzed by this method. 
PLS analysis of the absorbance spectra of spectrin (35 ± 5 mg/ml) in PBS7 .4 similar 
to that shown in figure 2a yields 59 ± 5 % (n = 5) a:-helix, 16 ± I % ,8-sheet and 26 ± 3 % 
other (Table 3). These values are in good agreement with the band fitting results outlined 
above with 55 % a:-helix, 9 % ,8-sheet and 29 % other (Table 2). Therefore, due to the 
objectivity and relative ease of the PLS method of analysis, all the spectra of the modified 
spectrin in H20 buffer samples were analyzed with the PLS method. 
3.2.4 Spectrin under Denaturing Conditions 
The FTIR data of spectrin molecules under denaturing conditions (high pH, high 
temperature and SDS treatment) are presented in Table 3. In the high pH (2 M NaOH) and 
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high temperature (80 °C, spectrum recorded at 20 °c, after heating) studies, the percentage 
of a-helix dropped about 10 %, from 59 % to 47 % and 49 %, respectively. The percentage 
of ,8-sheet remained nearly the same (11 % and 16 %, respectively). The structural 
components defined as other increased to 42 % and 35 %, respectively. The SDS treatment 
caused an increase in the ,8-sheet structure to 21 % and a decrease in o:-helix structure to 38%. 
3.2.5 Spectrin in 5P7.4/H20 Buffer 
The spectra of spectrin in 5P7.4 (no NaCl) were obtained to study the effect on the 
secondary structure of changing the ionic strength of the buffer. The results of the PLS 
analysis are 64 ± 4 % (n = 3) o:-helix, 16 ± 6 % ,8-sheet and 20 ± 6 % other (Table 3), similar 
to the results for spectrin in PBS7.4 with 150 mM NaCl. These results indicate that the 
secondary structure is not sensitive to ionic strength. If the H bonds, which maintain the 
secondary structure, are affected by the ionic strength of the buffer, one may expect to see 
a shift in the absorbance maximum for the o:-helix absorbance band. However, the second 
derivative analysis of the spectra reveal that its positions were the same (1651 cm-1 ) for 
spectrin in high salt buffer (PBS7.4) and in low salt buffer (5P7.4). Indeed if the H bonds 
were to change the helix would probably change and the total amount of helix as well as the 
position of the center position would change. However, since we see no change we can 
conclude that the helix is not affected locally by a change in ionic strength. 
3.2.6 Spectrin incubated with BPS LUVs 
The absorbance spectra of spectrin incubated with BPS LUVs in PBS7.4 were analyzed 
using the PLS method, and the results are similar to those of spectrin in PBS7.4, with 59 ± 1 
% (n = 2) o:-helix, 19 ± 1 % ,B-sheet and 23 ± 1 % other (Table 3). 
Table 3 Percentage of Secondary structure Components from PLS Analyzed Spectra of 
Spectrin and Modified Spectrin in 5P7.4 with Various Concentrations of NaCl. 
[NaCl] 
Treatment 
n 
«-helix 
p-sheet 
other 
150 mM 
5 
59 ± 5 
16 ± 1 
26 ± 3 
0 mM 
3 
64 ± 6 
16 ± 4 
20 ± 6 
150 mM 0 mM 
2 M NaOH 80 ·ca 
2 
47 ± 11 
11 ± 5 
42 ± 7 
1 
49 
16 
35 
150 mM 
1 % SDS 
2 
38 ± 5 
21 ± 4 
41 ± 2 
asample held at 80 ·c for 10 min, spectrum collected at 20 •c. 
150 mM 
BPS LUVs 
2 
59 ± 1 
19 ± 1 
23 ± 1 
°' 0 
CHAPTER IV 
DISCUSSION 
4.1 Validity and Sensitivity of FTIR to Determination of Secondary Structure 
To evaluate the validity and reliability of using FTIR as a tool to determine the 
secondary structure of spectrin, it is important to first discuss the potential problems in using 
FTIR analysis methods to quantitate secondary structure. Although band fitting methods to 
FSD deconvolved spectra are widely used in the literature (Byler & Susi, 1986; Wantyghem 
et al., 1990; He et al., 1991; Prestrelski et al., 1991), they are limited due to the following 
inherent problems. Care must be taken not to over-deconvolve the spectrum because over 
deconvolution produces negative side lobes on absorption bands and can result in artificial 
bands from noise or incomplete compensation of water vapor (Mantsch et al., 1988). 
However, since we used a relatively low FWHH maximum parameter, we avoided serious band 
area changes by not over deconvolving, as is evident by the absence of side lobes on our FSD 
deconvolved spectra. There is also a problem with assignment of the bands, and often a 
complete assignment cannot always be made. In addition, the helix and random coil band 
positions overlap greatly in the H20 spectra, therefore prudence must be used in assigning the 
proper band size to these bands. We have shown that these bands are better resolved in D20 
solution, but one must still be concerned with incomplete deuteration. Further difficulties 
in assignment may arise due to noise, water vapor, amino acid side chains or contaminants 
(Lee et al., 1990). Another problem which has been disputed in the literature is the 
assumption that the extinction coefficients of the bands assigned to the different structures 
are identical. Evidence for changes in extinction coefficients as proteins undergo 
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conformational changes is now emerging (Jackson et al., 1989). However, it appears that 
variations in cell path length are more important than variations in absorption coefficient (Lee 
et al., 1990). Therefore, within the experimental error the assumption that the extinction 
coefficients are the same is valid. Finally, the PLS method we employed uses only the 
proteins in H20 buff er which gives rise to very low protein absorptions compared to solvent 
absorptions. However, we performed careful and systematic subtraction of the background; 
thus eliminating spectral distortion due to the water absorption. 
When the band fitting method is judiciously applied the error in prediction of 
structure type is about 4 % (Byler & Susi, 1986), and for the PLS method we employed the 
error in prediction of structure type is reported to be about 5 % (Dousseau & Pezolet, 1990). 
An awareness of potential pitfalls and careful data collection can lead to an adequate 
prediction of secondary structure using FTIR. More importantly since the FTIR band fitting 
and FTIR PLS analysis gave similar values for the secondary structure components as the 
previous CD studies (Ralston, 1978), we have concluded that the values that we have 
determined are reliable. Further, since the potential error was less for PLS analysis method 
than the band fitting method, we decided to use the PLS method for the majority of our 
analysis. 
The secondary structural changes of spectrin treated with heat, 2 M NaOH and 1 % 
SDS detected by FTIR demonstrate the sensitivity of the FTIR method to structural changes 
in the molecule. Heat and alkaline treatment denature proteins and cause hydrolysis of the 
peptide bonds, yielding smaller fragments of the protein molecule (Stryer, 1981 ). The effects 
of these treatments were detected as a decrease in o:-helix content by about 10 %. SDS 
treatment had the greatest effect on the o:-helix content, which decreased from 59 ± 5 % to 
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38 ± 5 % and other structural components increased from 26 ± 3 % to 41 ± 2 %. SDS treatment 
has been shown, using gel filtration chromatography, to cause the spectrin molecule to unfold 
into a rod-like structure (Nozaki et al., 1976). It is important to note that the trends of 
change in secondary structure are considered more important than the exact percentage value 
because they demonstrate the sensitivity of the method. 
As a measure of the sensitivity of the a-helix band center position to the strength of 
H bond, we measured the FTIR spectrum in H20 and D20 buffer. The amide I and II band 
maxima shifted from 1651 cm-1 to 1648 cm-1 and from 1551 cm-1 to 1460 cm-1, respectively, 
upon changing from H20 buffer to the D20 buffer, thus reflecting the decreased strength of 
deuterium bonds as compared to hydrogen bonds (Jackson et al., 1991). Therefore, the 
technique is sensitive to the strength of the H bonds in spectrin. 
The position of the a-helix center frequency has been shown to vary from about 1640 
cm-1 to 1656 cm-1 depending on the length of the a-helix (Dousseau & Pezolet, 1990). The 
variation in peak frequency has been correlated with the proportion of distorted helical 
structures, such as those at the ends of a helix (disordered helix), compared to the standard 
a-helix (ordered helix). For proteins of high a-helical content, the lower the frequency of 
the a-helical band center correlates with a larger proportion of ordered helix to disordered 
helix. The a-helix center frequency at 1651 cm-1 for spectrin in PBS7.4/H20 is lower than 
that of hemoglobin (1655 cm-1) and higher than that of tropomyosin (1642 cm-1) (Dousseau 
& Pezolet, 1990), indicating that the proportion of disordered helix to ordered helix is less 
than that for myoglobin, which is made up of 8 short helical segments about 30 A long 
(Stryer, 1981 ), but lower than that in the fibrous tropomyosin molecule, which is a 2 stranded 
extended a-helical rod 385 A long (Stryer, 1981 ). Therefore, for proteins of high a-helical 
content, such as spectrin, the relative position of the helix center frequency can be used to 
get an estimate of the a-helix length. This result, that the length of the a-helix is between 
30 A and 385 A, supports a recent model of spectrin which predicts the helix length to be 50.5 
A (Parry et al., I 992 ). In this model, the I 06 amino acid structural repeating unit in spectrin 
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has a triple helical structure with a left handed coiled-coil structure stabilized by maximum 
ion pairing between the helices. The helices are held together by ionic bonds formed between 
charged amino acid side chains which are arranged in a heptad manner, ie. the periodicity of 
the amino acid types (polar or apolar) is repeated every seventh amino acid (a,b,c,d,e,/.g, 
where a and dare apolar and e and g are polar, Parry et al., 1992). Based on optimum ion 
pairing, the length of the axial repeat in this model is 50.5 A. 
4.2 Effect of Ionic Strength on Spectrin 
Decreasing the salt concentration causes the elution volumes of pure spectrin on 
agarose gels to decrease (Ralston , 1976) implying that the isolated spectrin molecules swell 
with decreasing ionic strength. Furthermore, erythrocyte skeletons, which are largely 
composed of a two-dimensional array of spectrin, reversibly expand and contract upon 
decreasing and increasing the buffer ionic strength (Shen et al., 1986; Svoboda et al., 1992). 
Thus, it is important to understand the structural response of spectrin to ionic strength. 
The Stokes radius is a convenient parameter to measure the response of a protein 
dimension in solution to changes in ionic strength. The Stokes radius for the spectrin dimer 
in 100 mM NaCl was reported to be 102 A (Kam et al., 1977) and for tetramer in 100 mM 
NaCl was 200 A (Ralston, 1978), as determined by hydrodynamic measurements in tris and 
phosphate buffer, respectively. However, carefully controlled experiments of the Stokes 
radius of spectrin in buffers of varying ionic strength had not been done previously. The 
Stokes radius of spectrin calculated by its sedimentation coefficient was shown to correlate 
with the partition coefficient (Kav) of gel filtration column chromatography (Kam et al., 
1977). Using gel filtration chromatography, we found that the Stokes radius of spectrin dimer 
in 150 mM NaCl was 124 A and increased to 178 A in buffer without NaCl. The radius for 
spectrin tetramer in 150 mM NaCl was 250 A and increased to~ 330 A in buffer without 
NaCl. The values in high salt buff er were slightly higher than the published values (Ralston, 
1978; Kam et al., I 977). Since the FTIR technique has shown to be sensitive to secondary 
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structural changes in spectrin under denaturing conditions and is sensitive to the strength of 
the H bonds, we used it to probe the effects of change in ionic strength on the spectrin dimer. 
The secondary structural components were not affected by NaCl concentrations in the buffer 
(Table 3), and the a-helix center peak frequency remained the same (1651 cm-1) indicating 
that the strength of the H bonds in the helix were not affected either. 
It is conceivable that the ionic strength in the medium affects the ionic interactions 
between the heptads as suggested in the coiled coil model (Parry et al., 1992) to change the 
relative spatial arrangement of the helices. When the helices are lined up to form maximum 
ion pairing, a shorter overall dimension is obtained. When the helices shift their vertical 
register, a longer overall dimension is obtained. The difference in the Stokes radius for 
spectrin dimers between low and high ionic strength buffers was about 54 A. If the helices, 
within the repeating unit, shift relative to one another by about 1-2 A, this could account for 
the increase in R 8 for the molecule, without any apparent or detectable change in secondary 
structure. Further, since FTIR is a spectral technique sensitve to the short range interactions, 
if there was a difference in the packing or length of the helix it would have been evident in 
the FTIR spectrum. A model, explaining our FTIR and Stokes radii data, based on the model 
presented by Parry et al., (1992) is presented in figure 4. 
4.3 Spectrin with BPS LUVs 
Spectrin has been shown to have an affinity for negatively charged lipid vesicles with 
a binding constant of Ka - 107 mol/L and to actually penetrate the lipid bilayer (Sikorski et 
al., 1987; Cohen et al., 1986). Therefore, we examined the secondary structure of spectrin in 
the presence of BPS LUVs. No change in secondary structure was detected with FTIR upon 
binding to BPS LUVs. These results are consistent with the hypothesis that a small positively 
charged domain on the spectrin molecule is responsible for the binding to negatively charged 
Figure 4 
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Model of 106 amino acid repeating domain of spectrin in high and low salt 
buffer. Model of spectrin 106 amino acid repeating segment as proposed by 
Parry et al. (1992) (left). Modified model in which the proposed a-helices 
have shifted slightly, by about 2 A, due to a lowering in ionic strength (right). 
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lipid bilayers (Mombers et al., 1980; Maksymiw et al., 1987). An application of this technique 
could be to test the spectrin-lipid interaction hypothesis that hydrophobic interaction is 
responsible for spectrin binding to zwitterionic lipids such as phosphatidylcholine and 
phosphatidylethanolamine (Mombers et al., 1980). In such cases a structural change would 
be expected because a greater change in structure would be required in exposing the 
hydrophobic interior of the spectrin molecule. More experiments must be done to elucidate 
the change in secondary structure of spectrin in the presence of phospholipid vesicles. 
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SUMMARY 
We have studied the heme oxidation kinetics of purified human hemoglobin (Rb) in 
the presence of lipid vesicles of dipalmitoyl phosphatidylcholine and bovine brain 
phosphatidylserine that exhibited minimal lipid peroxidation. We showed that the lipid 
vesicles enhanced Rb oxidation, and that small unilamellar vesicles (SUVs) exerted a larger 
effect than large unilamellar vesicles (LUVs). We have determined pseudo first-order rate 
constants for the initial disappearance of oxygenated ferrous Rb (k0 ) and for the initial 
formation of several ferric Rb species (methemoglobin, hemichrome and choleglobin) in the 
presence of SUVs and LUVs. k0 and other rate constants depended linearly on lipid-to-
hemoglobin molar ratio (Lipid/Rb), with k0 suv (h-1) = k0 auto (h-1) + 3.7 x 10-3 x Lipid/Rb, 
and k0 LUV (h-1) = k0 auto (h-1) + 0.2 x 10-3 x Lipid/Rb, where k0 auto is the rate constant for 
Rb autoxidation in the absence of vesicles. Thus, in the absence of lipid peroxidation 
products, lipid vesicles themselves promote Rb oxidation by enhancing the rate of Rb 
oxidation. The enhanced oxidation was inhibited by catalase, but not by butylated 
hydroxytoluene. The rate constants were independent of Rb concentration, in the range of 
about 3.1 µM to 100 µM. We suggest that the lipid surface properties, including surface 
curvature, surface energy and hydrophobicity, promote hemoglobin oxidation. 
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Extensive investigations of Hb1 oxidation using purified Hb in various buff er systems 
have been carried out (Weiss, 1964; Misra and Fridovich, 1972; Winterbourn, 1985a; Caughey 
and Watkins, 1985). Although the exact mechanism for heme oxidation in Hb or myoglobin 
is not clear (Shikama, 1990; Watkins et al., 1985; Shikama, 1984), quantitative studies have 
demonstrated that Hb autoxidation is mediated by protons, enhanced by anions (Wallace et al., 
1974), and may involve heme deoxygenation prior to electron transfer (Wallace et al., 1982). 
Most of these studies were carried out in the absence of membrane components, whereas in 
vivo Hb oxidation occurs in an environment enclosed by cell membranes. Furthermore, it has 
been shown that Hb interacts with membrane components on the inner leaflet of the 
erythrocyte (Kimelberg, 1976; Szundi et al., 1980; Fung, 1981; Shviro et al., 1982; 
Rauenbuehler et al., 1982; Kaul and Kohler, 1983; Walder et al., 1984). Thus, it is useful to 
study Hb oxidation in the presence of various lipid and other inner leaflet membrane 
components. 
The study of Hb oxidation in the presence of lipid molecules is also important in 
developing Rb-containing liposomes as oxygen-carrying fluid (Rabinovici et al., 1990; Ligler 
et al., 1989; Brandl et al., 1989). It is vital to maintain Hb in the reduced state in the presence 
of lipid to provide functioning Hb to carry oxygen in liposomes. 
Recent studies of lipid vesicle - Hb systems suggested that lipid peroxidation products 
caused spectral changes in oxyHb (Itabe et al., 1988; Szebeni et al., 1984; Szebeni et al., 1985; 
Szebeni et al., 1988). No kinetic data were provided in these studies - - probably, in part, 
due to some of the experimental difficulties that we discuss below. It was not clear whether 
the lipid bilayer exhibited intrinsic effects on Hb oxidation. In this work, we have monitored 
Hb oxidation in the presence of small and large unilamellar vesicles prepared from lipids with 
minimal peroxidation, and developed methods using optical spectroscopy to obtain kinetic 
information on the initial Hb oxidation in the presence of vesicles. Bovine brain 
phosphatidylserine (BPS), which contains unsaturated fatty acids, and dipalmitoyl 
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phosphatidylcholine (DPPC), which contains only saturated fatty acids, were used. BPS was 
selected for detailed studies, because PS is one of the major phospholipid components found 
in the inner leaflet of the erythrocyte membrane bilayer (Marinetti and Crain, 1978). 
Furthermore, BPS includes a mixture of saturated and unsaturated acyl chains similar to the 
chemical composition found in erythrocyte phospholipids (Ways and Hanahan, 1964; 
Yamamoto et al., 1985). Pseudo-first order rate constants for the initial disappearance of 
ferrous Hb, and for the formation of several ferric Hb species (methemoglobin, hemichrome 
and choleglobin) were determined for the Hb oxidation reactions in the presence of vesicles. 
The kinetic data showed that both SUVs and LUVs enhance Hb oxidation, but to different 
extents. Control experiments were carried out to ensure that lipid peroxidation products were 
not responsible for the observed vesicle effects. 
Hb Oxidation 
MATERIALS AND METHODS2 
RESULTS 
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A typical spectrum of partially oxidized oxyHb in the absence of lipid vesicles in 23 
mM sodium phosphate buffer with 2 mM EDTA and 127 mM NaCl at pH 7.4 (PEN7.4) 
showed reduced intensity at 540 and 577 nm, and increased intensity at 630 nm at time (t) = 
22 h, when compared with the oxyHb spectrum at t = 0 (Fig IA). These spectra were similar 
to published spectra obtained under similar conditions (Antonini and Brunori, 1972; Watkins 
et al., 1985; Winterbourn, 1985b). The addition of SUVs to Hb dramatically enhanced the 
reduction in intensity at 540 and 577 nm. Fig 1B shows that the time period to obtain spectra 
similar to those obtained in Fig IA was reduced from 22 h to about 30 min in the presence 
of SUVs at a lipid concentration of 2.3 mg/ml with Hb concentration at 0.21 mg/ml. These 
SUV-enhanced spectral changes were not observed when oxyHb was replaced with 
oxygenated hemolysate or COHb (Fig IC). 
The spectral changes observed in Fig 1B suggested lipid-enhanced Hb oxidation. 
After several potential problems were addressed3, the data were analyzed quantitatively to 
give kinetic information on the enhanced oxidation. 
Rate Constants 
Fig 2A shows the logarithmic values of oxyHb concentration as a function of time 
(rate constant plot, assuming that the oxidation is a pseudo first-order reaction) for a typical 
autoxidation experiment. The oxyHb concentrations remained linear for about 50 h in the 
absence of lipid vesicles. The slope obtained from the linear portion of these data was the 
pseudo first-order rate constant (k0 ) for the initial disappearance of oxyHb. A linear fit of 
data in Fig 2A yielded an autoxidation rate constant (k0 auto) of 0.018 h-1, with a correlation 
coefficient (R 2) of 0.998. Data from multiple runs gave an average k0 auto value of 0.030 ± 
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0.010 h-1, in good agreement with the published value of 0.042 h-1 (Watkins et al., 1985). 
Since metal ions are known to affect Hb oxidation, we have checked the effectiveness 
of EDTA for removing metal ions in samples. A Hb sample with 4 µM CuSO4 added in a 
buff er solution similar to PEN7.4, but without EDT A, exhibited a k0 auto of 0.417 h-1, more 
than an order of magnitude higher than those without added CuSO4 but in PEN7.4 buffer. 
The rate constant for the same sample, but treated with Chelex, was 0.031 h-1. The rate 
constant for a sample without Chelex, but with 2 mM EDTA was 0.022 h-1, and the rate 
constant for a sample in PEN7.4 buffer and with Chelex treatment was 0.025 h-1. The last 
three rate constants were in good agreement with the above-mentioned average k0 auto of 
0.030 h-1. Thus these data indicated that either Chelex or 2 mM EDT A treatment was 
sufficient to remove the metal ions in µM concentration in samples. All our samples were 
prepared in buffer containing 2 mM EDTA (PEN7.4). 
For a 0.20 mg/ml Hb samples containing about 2 mg/ml BPS SUVs, the linear portion 
in the rate constant plot shortened to about 12 min. A typical set of data, as shown in Fig 2B, 
exhibited an excellent linear fit (R2 of 0.998), to give a rate constant (k0 suv) of 3.91 h-1. The 
excellent linear fit suggests that reliable rate constants for the initial disappearance of oxyHb 
in the presence of lipid vesicles can be obtained optically. Reproducibility of these data was 
also very good. The average k0 suv value for six separate runs (with 0.20 ± 0.02 mg/ml Hb 
and 2.11 ± 0.03 mg/ml lipid) was 3.20 ± 0.52 h-1, with a coefficient of variability of 15.6 %. 
The average rate constants for the formation of metHb, hemichrome and choleglobin were 
also obtained from the data as 1.32 ± 0.20 h-1, 1.03 ± 0.23 h-1, and 0.33 ± 0.16 h-1, 
respectively. These values were also higher than the corresponding values for the autoxidation 
experiments (0.02 ± 0.01 h-1, < 0.01 h-1 and< 0.01 h-1, respectively). 
Lipid to Hemoglobin Molar Ratio 
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For most of the rate constant measurements, we held Hb concentrations constant at 
about 0.20 mg/ml (3.1 µM) and varied lipid concentrations, ranging from 0.25 mg/ml to 2.5 
mg/ml. These concentrations corresponded to lipid-to-Hb molar ratios (Lipid/Hb) ranging 
from about 100 to 1000, assuming a molecular weight of 64,000 for Hb and 800 for BPS. Fig 
3 shows that k0 suv depended linearly on Lipid/Hb, with a slope of 0.0037, to give the 
following relationship between k0 suv and Lipid/Hb. k0 suv (h-1) = k0 auto (h-1) + 3.7 x 10-3 
X Lipid/Hb. 
We also prepared samples with various Hb concentrations, ranging from 0.20 mg/ml 
(3.1 µM) to 7 mg/ml (109.3 µM), and lipid concentrations ranging from 0.25 mg/ml to 9 
mg/ml to maintain Lipid/Hb of 100 or 200. We found that at either Lipid/Hb value, the 
values of k0 suv remained similar as the Hb concentrations increased from 12.4 µM to 437 µM 
in heme (Fig 4). Since we could not prepare SUVs at about 18 mg/ml, we were unable to 
obtain a sample with Lipid/Hb of 200 and Hb concentration at about 400 µM in heme. 
Effects of BPS LUVs on Hb Oxidation Rate Constants 
We found that the extruded LUVs enhanced Hb oxidation to a lesser extent than 
sonicated SUVs, at similar Lipid/Hb. For LUVs at about 2 mg/ml lipid concentration and 
0.2 mg/ml Hb (Lipid/Hb = 800), the rate constants (k0 LUV) were about 0.29 ± 0.07 h-1 (n = 
7), about an order of magnitude higher than k0 auto, but an order of magnitude smaller than 
k0 suv_ The average values of the rate constants for the formation of metHb, hemichrome and 
choleglobin were 0.11 ± 0.02 h-1 (n = 7), 0.07 ± 0.02 h-1 and 0.04 ± 0.07 h-1, respectively. 
The LUY-enhanced oxidation rate constants also depended linearly on Lipid/Hb, with a slope 
of 0.0002 (Fig 5) to give k0 LUV (h-1) = k0 auto (h-1) + 0.2 x 10-3 x Lipid/Hb. 
Potential Artifacts in SUV and LUV Sample Preparations 
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Since it is well known that ultrasonic irradiation of water promotes the production of 
hydroxyl free radicals and hydrogen peroxide (Lorimer and Mason, 1987; Almog et al., 1991), 
it is crucial to check whether the different methods used in preparing these vesicles were 
responsible for the differences discussed above. We prepared LUVs from lipid extracted from 
SUVs with chloroform, methanol and water (Bligh and Dyer, 1959), and found that the k0 
for these SUV-extruded LUVs was similar to those of LUVs, as shown in Fig 5, indicating 
that sonication did not introduce artifacts in oxidation. We also subjected a sample of LUVs 
to sonication and centrifugation, similar to the steps used in preparing SUVs. The k0 for 
these LUV-sonicated SUVs was larger than for the control LUY sample, and was actually 
similar to those obtained for samples containing SUVs, as shown in Fig 3. Thus the effects 
observed with SUV and LUY samples were not simply due to artifacts in sample preparations. 
Effects of DPPC Vesicles 
We also prepared SUVs and LUVs with DPPC, which contains only saturated fatty 
acids. The k0 suv and k0 LUV values for DPPC are very similar to the corresponding ones for 
BPS, as shown in Fig 3 and Fig 5 respectively, indicating that neither the head group nor the 
degree of fatty acid saturation play a critical role in the enhanced oxidation process. 
Effects of BHT on Hb Oxidation Rate Constants 
The addition of butylated hydroxytoluene (BRT) (about 0.5 - 1.5 mM) to samples did 
not eliminate the vesicle-enhanced oxidation. For samples containing BPS SUVs, the average 
ratio of k0 SUV with and without BRT was 0.93 ± 0.26 (n = 18), with Lipid/Rb ranging from 
150 to 1000. For samples containing BPS LUVs, the average ratio of rate constants with and 
without BRT was 1.09 ± 0.73 (n = 12), with Lipid/Rb ranging from 1000 to 3000. 
Catalase Effects on Hb Oxidation Rate Constants 
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We added various amounts of catalase to purified Hb samples and monitored the 
oxidation in samples containing SUVs with a Lipid/Hb value ranging from about 100 to 1,000. 
Addition of low levels of catalase (200 units/gm-Hb) reduced the rate constant by about 30 
%, for example, from 2.5 h-1 to 1.8 h-1 for a Lipid/Hb of 800. Addition of catalase ( I ,500 
units/gm-Hb or more) reduced the rate constant by about 95 %, for example, from 2.4 h-1 
to 0.1 h-1 at a Lipid/Hb value of 930, and from 0.82 h-1 to 0.04 h-1 at a Lipid/Hb of 200. 
The effect of adding catalase to samples with oxidation already in progress was also 
studied. At t = 7 - 11 min after Hb was incubated with SUVs, the sample consisted of about 
70 to 80 % oxyHb and 20 - 30 % oxidized Hb. The oxidation rate decreased substantially 
upon addition of catalase (39,000 units/gm-Hb) (Fig 6). The rate constant at a Lipid/Hb of 
about 940 was about 2.2 h-1 before the addition of catalase. Upon addition of catalase at t 
= 7 min the rate constant decreased to about 0.4 h-1. These results demonstrate substantial 
inhibition of lipid-enhanced Hb oxidation by catalase. 
These results also suggest that catalase with a concentration of about 1.6 x 104 
units/gm-Hb may be responsible, at least in part, for the very slow oxidation observed in 
hemolysate samples containing SUVs (Fig IC). 
Lipid Peroxidation Products in BPS Vesicles 
Lipid peroxidation has been studied extensively in many biological samples. A 
number of techniques are available for measuring peroxidation. Each technique measures 
something different, and no one method by itself appears to be very accurate, but a 
combination of methods can be used to indicate the extent of lipid peroxidation (Gutteridge 
and Halliwell, 1990). To determine the concentrations of lipid peroxidation products in our 
vesicle systems we used the following three methods: (1) Conjugated diene assay with 
A233/ A215 values, (2) Assay for detecting malondialdehyde (MDA) and the thiobarbituric acid 
reactive products (TBARP), and (3) GC-mass spectrometry measurements for fatty acid 
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composition. Table I shows the results of these measurements. Also listed in Table I are 
literature values from various experiments, with conditions not necessarily the same as ours, 
to provide reference points for the level of lipid peroxidation as measured by these assay 
methods. For example, for conjugated diene measurements, a value of 0.08 was considered 
low, whereas a value of 0.66 was considered to be a high level of lipid peroxidation (Szebeni 
and Toth, 1986). The values for our SUVs and LUVs in Table I are less than 0.18, which 
suggest that little lipid peroxidation occurred in both SUV and LUY samples. For TBARP 
level, values of 4 - 18 nm MDA/µmol lipid (Szebeni and Toth, 1986), or 6 - 23 nm 
MDA/µmol lipid (Itabe et al., 1988) were observed in the presence of Rb-induced lipid 
peroxidation. Again, our values of 1.3 - 1.4 nm MDA/µmol lipid in SUVs and LUVs 
suggested that little lipid peroxidation occurred in the SUV and LUY samples. GC-mass 
spectrometry results showed that both the SUV and LUY samples consisted of essentially the 
same fatty acid compositions as those of the stock solution. Thus, our data suggest that both 
BPS SUVs and BPS LUVs exhibited very similar, i.e. very low levels of, lipid peroxidation. 
Since it has been reported that Hb is a biologic Fenton reagent (Sadrzadeh et al., 1984), and 
that Hb induces lipid peroxidation (Itabe et al., 1988; Szebeni et al., 1988), we also examined 
the vesicle samples after incubation with Hb for 30 min. However, since Hb interferes with 
the conjugated diene and MDA (Kikugawa et al., 1981) assays, we only carried out the GC-
mass spectrometry measurements on these samples. The data show little fatty acid 
composition change in vesicle samples before and after incubation with Hb for 30 min. Thus 
during the time period needed for our experiments, minimal Rb-induced lipid peroxidation 
was observed in all samples. 
Heme Concentration in BPS SUVs 
We incubated Hb (0.52mg/ml) with BPS SUVs (4.2 mg/ml) (Lipid/Hb = 673) for 2 h 
at 37 °c to obtain substantially oxidized Hb in the Rb-vesicle samples. The Hb and BPS SUVs 
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were then separated by column chromatography. We found that the total heme concentration 
in BPS SUVs was 0.08 ± 0.03 µmoles heme/g lipid (n = 4) in these samples. Since the starting 
Hb concentration corresponds to about 2 µmoles/g lipid, or 8 µmoles in heme/g lipid, the 
heme concentration detected in SUVs corresponds to about I % of the total heme in Hb. The 
choleglobin concentration in the sample under similar conditions was about 7 ± 3 %. No heme 
was detected in the vesicles separated from the column immediately after mixing with Hb (t 
= 0). 
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DISCUSSION 
The systems containing oxyHb and SUVs, or LUVs, in phosphate buffer were 
optically complicated, because oxy Hb, metHb, hemichrome, choleglo bin, and SUV s, or L UV s, 
as well as large vesicles from Hb-induced fusion of smaller vesicles (Fig 3-S in Miniprint) co-
existed at concentrations that varied with time. However, when the process of vesicle fusion 
induced by Hb was slower than that of oxyHb oxidation, reliable kinetic information for the 
initial oxidation process of Hb in the presence of SUVs, or LUVs, could be obtained optically 
in the 500 - 700 nm region. We emphasize that this work focused on the initial oxidation 
process. As oxidation proceeds, many additional molecular events, such as vesicle fusion, 
lipid peroxidation, etc. occur, and some of these have been reported (Szebeni and Toth, 1986; 
Szebeni et al., 1988; Itabe et al., 1988). 
Having the oxidation process described quantitatively in terms of pseudo first-order 
rate constants, we showed clearly that the initial Hb oxidation was enhanced by lipid vesicles. 
The rate constants for the initial disappearance of oxyHb, or for the appearance of metHb, 
hemichrome or choleglobin were much larger than those in the system without vesicles. 
Furthermore, the k values for systems containing SUVs were larger than those containing 
LUVs, with kosuv (h-1) = k0 auto (h-1) + 3.7 x 10-3 x Lipid/Hb, and 
k0 LUY (h-1) = koauto (h-1) + 0.2 x 10-3 x Lipid/Hb for Hb and vesicles in PEN7.4 buffer at 
37 °C. 
Assuming a 0.6 nm2 surface area for the BPS headgroup and a 4 nm bilayer thickness 
(Cullis and Hope, 1985), the number of vesicles and the number of BPS molecules exposed to 
the Hb molecules in the outer monolayer could be calculated, if the size of the vesicles was 
known. Assuming IO nm and 130 nm diameters in ideal SUV and LUY samples, respectively, 
we calculated that there were 1.4 x 1015 vesicles in SUV samples (I mg/ml BPS) and 4 x 1012 
in LUY samples. There are 7.2 x 1017 BPS molecules on the outer monolayer of I ml SUV 
samples, compared to 3.6 x 1017 molecules per ml for the LUY samples. Thus, the number 
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of BPS molecules accessible to Hb molecules was only about two times more in SUV samples 
than in LUY samples, despite the large differences in the size and number of vesicles in the 
two samples. Therefore the order of magnitude difference in rate constants seen in SUV - and 
LUY-containing samples is probably not due to a difference in the accessible lipid molecules 
to Hb molecules in the two vesicle systems. 
The differences in the values of ksuv and kLUV could not be attributed to lipid break-
down products from sonication or extrusion methods, or to different lipid peroxidation 
products in SUVs and LUVs. The rate constants of sonicated samples prepared from LUVs 
were the same as those for SUVs. Similarly, the rate constants of extruded samples prepared 
from SUVs were the same as those for LUVs. Lipid peroxidation assay data for both SUVs 
and LUVs showed similar, limited lipid peroxidation. Data from samples containing the lipid 
peroxidation inhibitor BHT were similar to those without BHT. In addition, BPS and DPPC 
vesicles exhibited similar effects indicating that the degree of fatty acid saturation did not 
play an important role in this process. It is interesting to note that in a study of Hb-induced 
lipid peroxidation, BPS was found to have both deleterious and protective effects on lipid 
peroxidation (Szebeni et al., 1988). In a similar study, it was found that hemoglobin did not 
induce lipid peroxidation when vesicles were prepared with low conjugated diene/lipid 
hydroperoxy content (Szebeni and Toth, 1986), in good agreement with our findings in 
detecting limited lipid peroxidation products in the samples. 
BPS and DPPC vesicles exhibited similar effects, indicating that there was little head 
group specificity in this vesicle-enhanced oxidation. 
In our studies, the hemoglobin concentrations were relatively low, ranging from about 
3 µM (0.2 mg/ml) to about 100 µM (7 mg/ml). At low Hb concentrations, Hb tetramers 
dissociate to dimers, which exhibit a much higher rate of heme dissociation than tetramers 
(Benesch and Kwong, 1990). Consequently, Hb autoxidation is enhanced by dissociation into 
dimers (Zhang et al., 1991). However, our data show that similar rate constants were obtained 
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from samples with the same Lipid/Rb but different Hb concentrations (Fig 4). We did not 
observe increased oxidation upon decreasing Hb concentration. On hydrogen peroxide 
induced oxidation of oxyHb Titov and coworkers also did not observe a Hb concentration 
effect, with Hb concentration ranging from 12 µM to 24 µM (Titov et al., 1991). Our Hb 
concentration range ( 12 µM to 400 µM in heme) is within the Hb concentration range (3 µM 
to I mM in heme) that exhibit sharp changes in autoxidation due to tetramers dissociation to 
dimers (Zhang et al., 1991). Thus our results indicate that the enhanced oxidation is not 
directly related to the concentrations of oxyHb tetramers and dimers. 
Hb interacts with erythrocyte membranes at low ionic strength (Kaul and Kohler, 
1983), with an equilibrium dissociation constant of about 10-4 Min 5 mM phosphate buffer 
at pH 8 (Fung, 1981). The interactions weakens to about 8.1 ± 5.6 x 10-5 Mat physiological 
ionic strength and temperature (Lilley and Fung, 1987). Hb also interacts with phospholipids. 
The electrostatic interactions (Szundi et al., 1980) and the hydrophobic interactions (Calissano 
et al., 1972; Papahadjopoulos et al., 1973) between Hb and PS have been observed. A model 
has been proposed to suggest that Hb interacts with the lipid surface initially by charge 
interactions, followed by insertion of the hydrophobic part of the globin into the lipid bilayer 
(Kimelberg, 1976). Shviro and coworkers suggested that the hydrophobic interactions in the 
model ref erred to a transfer of hydrophobic heme groups from Hb to the lipid bilayer, rather 
than a specific globin moiety interacting hydrophobically with PS (Shviro et al., 1982). 
Although apomyoglobin and apohemoglobin can extract heme from the lipid bilayer (Rose et 
al., 1985; Cannon et al., 1988), the affinity between CO-heme and globin (Light and Olson, 
1990) is higher than that of hemin and globin (Cannon et al., 1988). In addition, globin 
denatures at room temperature (Rose et al., 1985). In the presence of PS no interaction was 
found between globin and hemin (Shviro et al., 1982). The heme transfer rate constant 
between Hb and hemopexin was not detectable for COHb, whereas it was 0.9 h-1 for metHb 
(Hebbel et al., 1988). We have detected about 1 % of heme in SUVs after 2 h incubation with 
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oxyHb. Our detection method does not distinguish between reduced and oxidized forms of 
heme since all hemes are converted to porphyrin in the process of detection. About 7 ± 3 % 
choleglobin was detected under similar conditions (Fig 4-S in Miniprint). Thus it is plausible 
that in our samples the oxidized Hb interacts with the lipid surface, facilitating the transfer 
of oxidized heme to the lipid bilayer. The enhancement of oxidation is probably not due to 
any specific Hb unfolding reaction at the membrane surface, but due to dissociation of hemin 
from Hb, resulting in globin and hemin precipitation. The lipid bilayers serve to solubilize 
the hemin, allowing it to catalyze the production of strong oxidants, particularly hydrogen 
peroxide and hydroxide radicals, which promote further Hb oxidation. Our catalase results 
support this hypothesis. Catalase mediates the removal of hydrogen peroxide (Deisseroth and 
Dounce, 1970). The addition of sufficient catalase arrests the induced oxidation. Our data 
are in agreement with the finding that the addition of catalase a short time after the addition 
of hydrogen peroxide arrested further oxidation of Hb (Titov et al., 1991). This hypothesis 
suggests that the ability of a lipid surface to enhance Hb oxidation depends on its ability to 
solubilize the hemin generated from oxidized Hb. 
The SUVs and LUVs have very different curvatures, calculated as 2/diameter (Protter 
and Morrey, 1970), and therefore different surface chemistry due to the different 
intermolecular forces associated with the individual vesicle systems (MacDonald, 1990; Ohki 
and Duax, 1986; Ohki, 1984). For the strongly curved bilayer in SUVs with diameter of about 
10 - 30 nm (Fig lA-S in Miniprint), the strength of the lateral forces, tending to divide the 
phospholipid molecules, closely approximates the strength of the hydrophobic interactions 
holding them together (Gray and Morgan, 1991). Thus SUVs become more susceptible to 
solubilization by, for example, lipoproteins (Scherpof et al., 1979). Furthermore, SUVs fuse 
much more readily than LUVs (Szoka, 1987; Diizgiines and Bentz, 1988; MacDonald, 1988). 
With the high curvature, the hydrophobic (hydrocarbon) moieties of SUVs have a larger 
exposure to water. Thermodynamic analysis indicates that membrane surface pressure can 
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account for differential activities of any membrane-penetrating molecules (MacDonald and 
MacDonald, 1988). LUVs exhibit surface curvatures different from those of SUVs 
regardless of the size of the filters used to extrude them. The LUVs extruded with 30 nm, 
50 nm and 100 nm filters have overlapping size distribution. For example, the mean 
diameters of extruded PC vesicles prepared with an extruder similar to the one we used in our 
studies are given as I 03 ± 20 nm for I 00 nm filter, 68 ± 19 nm for 50 nm filter and 56 ± 17 
for 30 nm filter (Mayer et al., 1986). Extrusion may not be capable of giving small vesicles 
that have significant strain as in sonicated vesicles. Since it seems impossible to make vesicles 
much smaller than 60 nm with extrusion, it may be that the vesicles choose the smallest strain-
free state even when it is larger than the filter pore diameter. It has been reported that 
vesicles with low curvature are more readily destabilized by proteins like spectrin than 
vesicles of high curvature (Subbarao et al., 1991). It appears that the SUVs are highly 
strained, whereas the LUVs are more relaxed. Thus the differences in surface chemistry in 
SUVs and LUVs may facilitate the transfer of oxidized heme from Hb to vesicles differently, 
and thereby increase the kinetics of Hb oxidation to different extents. 
Whether the lipid effects observed in this study have physiological significance is not 
clear. The Hb concentrations in erythrocytes are much higher than those used in this study, 
and thus the lipid-to-Hb molar ratios used in this study may be relatively high compared to 
those in the erythrocyte. However, Hb molecules and lipid molecules in erythrocytes do not 
mix. It is not clear whether a simple molar ratio of inner leaflet lipid molecules to total Hb 
molecules in red blood cells is relevant for our consideration. Within the erythrocyte, a 
fraction of the Hb molecules closely associated with the inner membrane leaflet at any one 
time. The membrane-associated Hb molecules exhibit time-dependent exchange with the 
bulk erythrocyte Hb molecules. With the surface area of a lipid head group being 0.6 nm2 
(Cullis and Hope, 1985), and the projected surface area of Hb being 24 nm2, one Hb molecule 
may interact with about 40 lipid head groups at the interface to form a single layer of closely 
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packed Hb next to the lipid monolayer surface at any moment. At this Lipid/Hb value of 40, 
k0 suv would be about 0.2 h-1, an order of magnitude higher than k0 auto_ In studying the Hb 
effect on liposome permeability, Calissano and coworkers found that about 0.4 nmoles of Hb 
bound to one µmole PS (Calissano et al., 1972; Kimelberg, 1976). Their results suggest a 
Lipid/Hb of 2500. At this ratio, our studies show that SUVs would increase the oxidation by 
several orders of magnitude. However, the curvature of the erythrocyte surface is much 
larger than those of SUVs, and may be more appropriately described by LUVs. Further 
studies on the spatial distribution of phospholipids (lipid patches) in the inner leaflet of 
erythrocyte and the physical interactions between lipid and Hb will be useful in determining 
lipid effects on Hb oxidation in erythrocytes. It is also interesting to note that the inhibitory 
effect of catalase in red cells. It is possible that the presence of this enzyme prevents much 
of the lipid enhanced oxidation in erythrocyte. 
The overall mechanism for lipid enhanced Hb oxidation is likely to be quite 
complicated, and its formulation will require further quantitative studies to provide kinetic 
parameters under experimental conditions that are known to affect (1) oxyHb autoxidation, 
(2) physical interactions between lipid and oxyHb, metHb or hemichrome molecules, and (3) 
the interactions of the heme group with the protein moiety in oxyHb, metHb and hemichrome 
molecules, and with different lipid surfaces to delineate various molecular events in the Hb -
lipid mixture. It is also important to study the surface chemistry of lipids on the inner leaflet 
of erythrocytes to understand how lipid molecules affect Hb oxidation in vivo. Our findings 
suggest that the physiological significance of lipid-enhanced Hb oxidation should be further 
studied. 
The findings also indicate that LUVs are substantially more desirable than SUVs for 
maintaining Hb stability in liposomes when used as an oxygen-carrying fluid. The SUV and 
LUY systems may also provide a quantitative means for studying anti-Rb-oxidation in 
liposomes. 
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1The abbreviations used are: BHT, butylated hydroxytoluene; BPS, bovine brain 
phosphatidylserine; CO, carbon monoxide; COHb; carbon-monoxy Hb; DPPC, dipalmitoyl 
phosphatidylcholine; Hb, human hemoglobin; k0 , pseudo first-order rate constant for the 
initial disappearance of oxyHb; LUY, large unilamellar vesicles; MDA, malondialdehyde; 
oxyHb, oxygenated Hb; PEN7.4, 23 mM sodium phosphate buff er with 2 mM EDT A and 
127 mM NaCl at pH 7.4; RP, reactive products; SOD, superoxide dismutase; SUV, small 
unilamellar vesicles; TBA, 2-thiobarbituric acid; TE8.3, 50 mM Tris buff er with 0.1 mM 
EDT A at pH 8.3. 
2The "Materials and Methods" section is presented in miniprint at the end of this paper. 
3The discussions on potential problems are presented in miniprint at the end of this paper. 
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FIGURE LEGENDS 
Fig 1: Spectra from 500 to 700 nm at 37 °C of (A) Hb (0.21 mg/ml) at t = 0 (top) and t = 22 
h (bottom), using PEN7.4 buffer as a blank, (B) Hb (0.21 mg/ml) and BPS SUVs (2.3 
mg/ml) at t = 0 (top), 12 min (middle) and 30 min (bottom), and (C) hemolysate (0.20 
mg/ml) and BPS SUVs (1.2 mg/ml) at t = 0 and 30 min (top two spectra, spectra were 
offset by 0.1 absorbance unit), and COHb and BPS SUVs (1.5 mg/ml) at t = 0 and 2 
h (bottom two spectra). BPS SUVs with matching lipid concentrations were used as 
blanks for spectra in (B) and (C). 
Fig 2: Semilogarithmic plot of percentage of oxyHb as a function of time, for (A) oxyHb in 
the absence of BPS SUVs and (B) in the presence of BPS SUVs. OxyHb solution (0.19 
mg/ml) was incubated at 37 °C in the presence of BPS SUVs (2.1 mg/ml) in PEN7.4 
buffer. Spectra were collected every 2 min in the presence of BPS SUVs and every 
10 min in the absence of BPS SUVs. In the presence of BPS SUVs the data are linear 
up to the first 12 min, while in the absence of BPS SUVs the data are linear up to 50 
h. The solid lines are a linear fit of the linear portion of the data points, with slope 
in (A) as 0.018 h-1 and in (B) as 3.91 h-1. The correlation coefficients for both linear 
fits were 0.998. 
Fig 3: Pseudo first-order rate constants for the disappearance of oxyHb (k0 suv) in the 
presence of BPS SUVs as a function of lipid-to-Hb molar ratio (Lipid/Hb) in PEN7.4 
buff er. The Hb concentration was held at about 0.20 mg/ml. The solid line was the 
linear fit of all data points, with a slope of 0.0037 and a correlation coefficient of 
0.850. The data from samples containing DPPC sonicated vesicles are in shaded 
symbols ( 0. ). The rate constant of the SUV sample prepared from LUVs is shown 
with a star symbol ( * ). 
Fig 4: The average pseudo first-order rate constants (n = 2) for the disappearance of oxyHb 
(k0 suv) in the presence of BPS SUVs as a function of Hb concentration, in heme 
97 
(mM). The samples were held at a constant Lipid/Rb of about 100 (e ) and about 200 
( ■ ). The error bars indicate the standard deviations of the average values. 
Fig 5: Pseudo first-order rate constants for the disappearance of oxyRb (k0 LUV) in the 
presence of BPS LUVs vs lipid-to-Rb molar ratios (Lipid/Rb) in PEN7.4 buffer. 
LUVs were prepared by extrusion methods, either with 100 nm,(■ ) 50 nm ( ♦ ) or 
30 nm filters ( • ). The line is the linear fit of the data points with a slope of 0.0002 
and a correlation coefficient of 0.867. The data from samples containing DPPC 
LUVs, extruded with 50 nm filter, are in shaded symbols ( o ). The star symbol ( * 
) is for the sample in which the lipid was extracted from an SUV sample and made 
into LUVs. The dotted line is the same line fitted to the data shown in Fig 3 for BPS 
SUVs, and is re-plotted for comparison. 
Fig 6: OxyRb oxidation in the absence (shaded symbols) and in the presence (filled symbols) 
of catalase (39,000 units/gm-Rb). Catalase was added after Rb was incubated with 
BPS SUVs at 37 °C for 7 min ( • ) in one sample and 11 min(■ ) in another sample. 
The initial Rb concentration was 0.21 mg/ml and the lipid concentration was 2.4 
mg/ml to give a Lipid/Rb of 940. 
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TABLE I 
Lipid Peroxidation Measurements of Various Lipid Samples 
Method Sample 
BPS Stocka SUVsb LUVsc SUVs + Hbc LUVs + Hbc 
A233/A215 d 0.0 0.176 0.149 NAe NA 
(n = 4) ± 0.102 ± 0.101 
TBARP 1.015g 1.385 l.312 NDh ND 
(n = 4) ± 0.035 ± 0.175 ± 0.117 
GC 16:0 0.9 0/oj 5.0 NMk 2.8 1.5 
± 0.2 
18:0 39.9 % 38.8 NM 38.9 42.1 
± 0.9 
18:1 32.6 % 38.3 NM 39.1 43.3 
± 11.9 
22:6 8.5 % 0 NM 0 0 
± 3.1 
20:4 2.9 % 1.3 NM 0 1.2 
± 0.9 
20:1 1.9 % 3.0 NM 2.6 2.6 
± 0.1 
others 13.3 %1 13.6 NM 16.6 9.3 
± 0.1 
asample as supplied by manufacturer. hsee Method Section for SUV and LUY preparations. 
csuvs and LUVs with about 2.3 ± 0.2 mg/ml lipid and oxyHb (about 2.3 ± 0.2 mg/ml), 
incubated at 37 °C for 30 min, a time period longer than those used in Hb oxidation. asee 
Methods sections for the methods used for lipid peroxidation measurements. esample not 
appropriate for assay, since Hb interferes with the absorbance readings. gin nm MDA/ µmole 
lipid. hAssay not done since MDA binds to Hb (Kikugawa et al., 1984). iAverage values of 
7 lots of BPS samples obtained from manufacturer's data sheet. kNot measured. 1Consists of 
14:0, 16:1, 18:2, 18:3, 20:0, 20:2, 20:3, 22:0 and 22:1; all less than 1 % each. 
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PHOSPHOLIPID VESICLES PROMOTE HUMAN HEMOGLOBIN OXIDATION 
by 
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I. MATERIALS AND METHODS 
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Unless stated otherwise, all experimental steps were carried out at 4 °C, and all 
chemicals were reagent grade from Fisher (Pittsburgh, PA), Sigma (St. Louis, MO) or Aldrich 
(Milwaukee, WI). HPLC-grade water was used for all buffers. All glassware was acid-
washed. 
Hemolysate Preparation. Human red blood cells were used within one week of withdrawal 
and washed with 5 mM sodium phosphate containing 150 mM NaCl, saturated with carbon 
monoxide (CO), at pH 7.4. The cells were lysed with 2 volumes of deionized water, followed 
by ammonium sulphate precipitation and desalting with a P6DG column (BioRad, Richmond, 
CA), equilibrated with 5 mM Tris buffer containing 150 mM NaCl at pH 7.5 to remove 
ammonium sulphate and other small molecules, including 2,3-bisphosphoglycerate, which 
affects hemoglobin autoxidation (Mansouri and Winterhalter, 1974; Kikugawa et al., 1981), 
to give stripped hemolysate. The hemolysate solution was dialyzed against 23 mM sodium 
phosphate buffer with 2 mM EDTA and 127 mM NaCl at pH 7.4 (PEN7.4), saturated with 
CO. If not used immediately, the hemolysate was frozen drop-wise in liquid N2 and stored 
at -80 °C. After thawing, the hemolysate was centrifuged at 38,000 g for 10 min before use. 
Superoxide dismutase (SOD) and catalase activities were determined in the hemolysate 
samples. The SOD extraction methods of Winterbourn and coworkers (1975) and the reaction 
cocktail conditions of Fridovich (1985) were used. The catalase activity was determined by 
the method of Claiborne ( 1985). Full SOD and catalase activities were detected in the stripped 
hemolysate samples, with SOD activity about 1.3 x 103 units/gm-Rb, and catalase activity 
about 1.6 x 104 units/gm-Rb, similar to the activities published for erythrocytes (Das and 
Nair, 1980). 
Hemoglobin Preparation. Hb was isolated from the stripped hemolysate solution according 
to a modified column chromatography procedure (Kawanishi and Caughey, 1985; Watkins et 
al., 1985; Winterbourn, 1985a). The stripped hemolysate was dialyzed in 50 mM Tris buffer 
with 0.1 mM EDTA at pH 8.3 (TE8.3), followed by CO gassing. A DEAE-Sephadex A-50 
(Pharmacia, Piscataway, NJ) column was used with a linear pH gradient made from buffer 
TE8.3 and a similar buffer at pH 7.0. The Hb fractions were concentrated, dialyzed against 
PEN7.4, and CO gassed to give carbon-monoxy Hb (COHb). This procedure removed all 
minor hemoglobin components, catalase, SOD, "adventitious" metals, and other red cell 
proteins to give "ultra-pure" HbA (Watkins et al., 1985; Winterbourn, 1985a). No SOD or 
catalase activities were detected in these Hb samples, using assay methods noted above. 
Some COHb samples were passed through a Chelex (BioRad, Richmond, CA) column 
to remove any residual trace metal (e.g., Cu and Fe) ions (Dunn et al., 1980; Chiesi and Inesi, 
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1980). 
Hb Concentration. The total Hb concentrations in the hemolysate and Hb solutions were 
determined by the cyano-met method (Riggs, 1981). In addition, at the beginning of each 
oxidation experiment, the concentration of the oxygenated Hb (oxyHb) solution was deter-
mined at 577 nm, using an extinction coefficient of 15.0 mM-1 cm-1 (Winterbourn, 1985a). 
No detectable absorbance at 630 nm was observed. The concentrations of oxyHb generally 
agreed to within 5 % with the values determined by the cyano-met method. 
Lipid Vesicles. BPS was purchased from Avanti Polar Lipids (Alabaster, AL), and DPPC 
from Sigma. Both were used without further purification after verification of purity by thin-
layer chromatography. Chloroform in lipid was removed with N2 gas followed by pumping 
under vacuum. If necessary, the lipid films were stored, but no longer than 48 h, at -20 °C 
under a N2 atmosphere. PEN7.4 buffer solution (5 ml) was saturated with N2 gas, and added 
to the lipid film. Some buff er solutions were treated with Chelex. The solution was hand-
swirled in the presence of glass beads to give multilamellar vesicles. For samples containing 
BHT, 0.5 to 1.5 mM BHT was added to the original lipid-chloroform solution. 
SUV s. SUV s were prepared from the multilamellar vesicles by slightly modified procedures 
of Itabe and coworkers (1988). Multilamellar vesicles in PEN7.4 were sonicated to clearness, 
under N2 at room temperature for BPS, and at 45 °C for DPPC, for about 20 min using a 
probe tip sonicator (Heat Systems-Ultrasonics Model W-10), and centrifuged at 38,000 g and 
20 °C to remove any large multilamellar vesicles and titanium from the sonication probe. 
Sonication conditions were precisely controlled to obtain consistent SUV samples. Otherwise, 
irreproducible, but generally much faster, oxidation was observed. The SUV samples were 
used immediately for oxidation studies. Lipid concentrations in these samples ranged from 
0.25 to 9 mg/ml, but were generally about 2.5 mg/ml. Freeze fracture electron 
micrographs of these SUVs, obtained by Lipex (Vancouver, Canada), showed typical SUVs 
with vesicle diameters ranging from 10 - 30 nm (Fig lA-S). Some larger vesicles were also 
seen. 
LUVs. LUVs were prepared from the multilamellar vesicle solutions (1 mg/ml to 14 
mg/ml) by extrusion methods with a lipid extruder (Lipex) (Loughrey et al., 1990). Polycar-
bonate filters (Nuclepore, Pleasanton, CA) with 30, 50 or 100 nm pore sizes were used. BPS 
vesicles were extruded at room temperature, and DPPC vesicles at 45 °C. Freeze fracture 
electron micrographs showed that the LUVs extruded with 100 nm filter exhibited diameters 
of about 100 nm (Fig lB-S). These LUVs were also analyzed by a particle sizer (a service 
provided by Lipex), and exhibited an average diameter of 130 ± 30 nm, in good agreement 
with the published value of 138 nm for egg phosphatidylcholine (Mayer et al., 1986), indi-
cating that these vesicles are much larger than SUVs. 
Lipid Concentration. Lipid concentrations of the vesicle samples were determined by the 
method of Stewart (1980), following extraction from the aqueous phase (Bligh and Dyer, 
1959). Extinction coefficients of 1.99 mg-1 cm-1 for BPS, and 4.12 mg-l cm-1 for DPPC 
were obtained experimentally, in good agreement with the published value (Stewart, 1980). 
Lipid Peroxidation Products. The concentrations of lipid peroxidation products in SUVs and 
LUVs were estimated by three methods: conjugated diene assay, A233/ A215 , TBARP assay, 
and GC-mass spectrometry. 
The conjugated diene assay followed the method of Klein (1970), using the ratios of 
the absorbances at 233 and 215 nm as an indication of the conjugated diene content. 
MDA and other TBARP were determined using standard procedures (Buege and Aust, 
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1978; Aust, 1985). The extinction coefficient was determined from MDA solutions of known 
concentrations, and agreed well with the literature value of 1.56 x 105 M-1 cm-1 (Aust, 1985). 
For GC-mass spectrometry measurements, the lipids were first converted to fatty acid 
methylesters (Van den Berg et al., 1988). The fatty acid compositions were then determined 
using a GC-mass spectrometer (at the University of Illinois at Chicago) with a Supelco 2330 
capillary column (Bellefonte, PA). 
Heme Detection in Vesicles. In the heme assay, the heme or hemin was converted to porphyrin 
for fluorescence detection (Morrison, 1965; Shaklai et al., 1985). A calibration curve was 
prepared using Hb solutions ranging from 0.31 µM to 3.13 µMin heme (0.005 to 0.05 mg/ml 
in Hb). Specifically, 50 µl of the standard Hb solution was added to 2 ml oxalic acid solution. 
The mixture was vortexed and incubated at 100 °C for 30 min. After cooling to room 
temperature, fluorescence intensity was measured using an excitation wavelength of 403 nm 
and an emission wavelength of 60 I nm. 
Hb (0.52 mg/ml) was mixed with BPS SUVs (4.2 mg/ml) and incubated at 37 °C for 
2 h. The vesicles and Hb were then separated by gel filtration on a Sepharose 4B-CL (Pha-
rmacia) column (41 cm x 1.5 cm) with a flow rate of 12 ml/h, similar to the method outlined 
by Szebeni et al. (1988). The vesicles eluted with the void volume. The Hb eluted about 3 
h later, thus yielding a very clean separation of vesicles and Hb. The vesicle fractions were 
pooled and pelleted by centrifugation at 38,000 g for 90 min. The pellet was then taken up 
in a small volume of buffer (100 - 200 µl) and assayed for heme and lipid concentrations. 
Another portion of the Hb and vesicle mixture was loaded to the column immediately after 
mixing (t = 0) to serve as a control sample. 
For the assay, 3 µl of Triton X-100 was added to a vesicle sample (25 µl) to solubilize 
the lipid, followed by I ml of oxalic acid solution for fluorescence measurements. It was 
found that if no Triton was added or if the Triton was added after the oxalic acid, a precipi-
tate was formed causing light scattering. 
Optical Measurements of Hb and Vesicle Mixtures. COHb was converted to oxyHb on ice 
under a flood light and 0 2 atmosphere immediately before the experiment. Optical spectra 
were monitored from 500 to 700 nm to ensure complete conversion, and to ensure that there 
was no detectable oxidized Hb in the samples. Samples with detectable oxidized Hb were 
discarded. The concentration of Hb was adjusted to 17 .5 ± 0.3 µM ( 1.12 ± 0.02 mg/ml) for 
most experiments. This cold oxyHb solution (120 µl) was introduced to a pre-warmed (37 ± 
0.5 °C for about 5 min) solution of lipid vesicles (500 µl) of known concentration in the range 
from 0.25 mg/ml to 2.5 mg/ml for SUVs, or from l mg/ml to 14 mg/ml for LUVs, to give 
a final Hb concentration of 0.22 ± 0.02 mg/ml (3.4 ± 0.3 µM). Samples with higher final Hb 
concentrations, about 1.0 mg/ml and 7 .0 mg/ml, were also used with SUVs (ranging from 1.25 
mg/ml to 9 mg/ml) to give Lipid/Hb of 100 or 200 to study the potential Hb concentration 
effects. In the optical measurements, vesicle solutions with lipid concentrations the same as 
samples were used as blanks. The sample cuvettes (with I cm or 2 mm path lengths) were 
covered with parafilm, and maintained at 37 ± 0.5 °C. Spectra were collected from 500 to 700 
nm every 2 min for 30 min. In experiments without lipid vesicles, buff er was used as a blank, 
and spectra were collected every 10 min for the first hour, and then periodically for 24 - 130 
h, if necessary. In some experiments, COHb or oxygenated hemolysate was used instead of 
oxyHb. 
Concentrations of Hb Species during Oxidation. In oxidized samples, oxyHb is oxidized to 
metHb, hemichrome, and choleglobin, following the definitions of Winterbourn (1985b). 
Thus the absorbance values at different wavelengths can be analyzed as a four-component 
(oxyHb, metHb, hemichrome and choleglobin) system at 560, 577, 630 and 700 nm to deter-
mine the concentrations of each Hb species in oxidized samples (Winterbourn, 1985a). The 
concentration of a component was set to zero if the analysis gave a negative value. The 
relative concentrations (percentages) for each component were then determined. 
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Rate Constant Determination. Rate constants for the disappearance of oxyHb or the appear-
ance of oxidized Hb were obtained from linear regressions (Systat program, Systat Inc., 
Evanston, IL) of the linear portions of the logarithmic plots of percent Hb versus time. 
II. POTENTIAL PROBLEMS IN OBTAINING KINETIC DAT A FROM OPTICAL 
DATA 
Spectral Baseline. The vesicle samples showed significant spectral absorption in the 500 to 
700 nm region (Fig 2-S, Curve A) due to light scattering by vesicles. Thus vesicle solutions, 
critically matched in both lipid concentration and vesicle size were used as blanks for the 
oxidation experiments to compensate for light scattering induced baseline distortion. Since 
meta-stable vesicles fuse to give larger vesicles (Ohki, 1984), the spectra could still include 
signal from lipid vesicles as well as Hb species if the fusion process in both compartments 
were not the same. Analysis of Hb component concentrations from these spectra would then 
be subjected to systematic error. Our freeze-fracture electron micrograph (Fig 3-S) showed 
that, after incubation with oxyHb, the vesicles were substantially larger than those produced 
from spontaneous SUV fusion during the same time period (Fig IA-S). Similar vesicle aggre-
gation and fusion are observed in protein-liposome conjugates (Loughrey et al., 1990) and 
BPS SUVs incubated with ca++ (Wilschut et al., 1981). Thus, a baseline rise was expected for 
a sample containing oxyHb and vesicle after 6 h incubation due to vesicle fusion and Hb 
oxidation, with the A700 reading increasing from 0.00 to about 0.06 (Fig 2-S, Curve C). The 
conversion of oxyHb to oxidized Hb species, especially choleglobin, also causes the baseline 
to increase (Winterbourn, 1985a; MacDonald and Charache, 1982). In the absence of lipid 
vesicles, an extensively oxidized Hb sample produced a readable A700 value, but the value was 
less than 0.01 (Fig 2-S, Curve B). Centrifugation (at 38,000 g for 10 min) of these extensively 
oxidized Hb samples did not change the absorbance readings. Thus we concluded that when 
A700 > 0.01, the vesicle fusion contribution to baseline was significant, and reliable Hb 
concentrations were not obtainable. It should be noted that this A700 cutoff value of 0.01 only 
applies to samples with total Hb concentrations of about 0.2 mg/ml. 
Fig I B in the main text indicates that, even for t < 30 min, a small increase in the 
baseline was observed for Hb samples containing SUVs, with A700 about 0.007. This could 
be interpreted as (a) SUV-induced formation of denatured Hb, including choleglobin, (b) Rb-
induced vesicle fusion, or both (a) and (b). It is difficult to specifically delineate the cause 
of this slight increase in baseline at the beginning of the oxidation process. If the increase 
was due to Rb-induced vesicle fusion, the slight increase in baseline would give an over-
estimation of Hb concentration by about 3 - 4 %, since the maximum absorbance at 577 nm 
was about 0.20. As detailed below, our total Hb concentration determined from A677 agreed 
with the value determined by the cyano-met method, thus we believe that the slight increase 
in baseline observed in Fig 1B was due to either (a), or (a) and (b ), but not due to (b) alone. 
Therefore the initial baseline increase may overestimate Hb concentration by about 3 % at 
most. 
Under most of the conditions studied, oxidation appeared to proceed relatively faster 
than the process of induced vesicle fusion. Thus, during the time period to collect data for 
kinetic studies, A700 did not exceed 0.01, and reliable Hb concentrations can be obtained from 
the spectra. However, if oxidation proceeded slower than induced vesicle fusion, such as the 
case when hemolysate was added to SUVs, the A700 values would rise to above 0.01 before the 
entire linear portion of the data were collected (data not shown). The kinetic parameters for 
these systems could not be obtained with confidence. 
Hb Concentration. Another potential problem comes from the Hb concentration analysis. The 
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sum of the concentrations of all Hb species, oxidized and not oxidized, obtained from spectral 
analysis should remain constant throughout the oxidation experiments. At the beginning of 
the experiment (t = 0), only one Hb component, namely the oxyHb, was present in the 
samples. The oxyHb concentrations determined from A577 for a set of samples with and 
without lipid vesicles were, for example, 0.211 and 0.194 mg/ml, respectively. The total Hb 
concentrations determined by the cyano-met method were 0.208 and 0.191 mg/ml, respec-
tively. Thus for both samples with and without lipid vesicles at t = 0, the concentrations ob-
tained by the A577 and the cyano-met method agreed to within 5 %. 
At t > 0, the sum of the concentrations of Hb species obtained from two-component 
analysis, a method often used in autoxidation analysis (Winterbourn, 1985a), decreased from 
0.208 mg/ml to 0.177 mg/ml, which represented a 16 % decrease, in samples containing SUVs. 
With four-component analysis, the sum of the concentrations of oxyHb, metHb, hemichrome 
and choleglobin remained constant, and agreed to within 5 % with the total Hb concentration 
determined by the cyano-met method. Thus inclusion of spectral contributions from hemi-
chrome and choleglobin was necessary to accurately account for the relative concentration 
measurements of Hb species in solutions containing SUVs during oxidation. 
These findings indicated that two-component analysis should not be used for these 
studies, due to significant amounts of hemichrome and choleglobin formation, but that the 
four-component analysis was adequate. Thus it was crucial to check the total Hb 
concentration to ensure that concentrations of the various Hb components in the samples were 
accurate. 
Concentrations of Reduced and Oxidized Hb Species. With the spectra properly analyzed by 
the four-component method, the relative concentrations of various Hb components were 
obtained as a function of time. Fig 4-S shows the concentrations as a function of time in a 
typical sample with Hb and SUVs in PEN7.4. After incubation of Hb (0.19 mg/ml) with 
SUVs (2.1 mg/ml) at 37 °C for 30 min, less than 30 % oxyHb remained in solution. The 
majority of the Hb molecules had converted to metHb (about 40 %), hemichrome (about 20 %) 
and choleglobin (about 10 %). The concentrations of Hb species in the same buffer without 
SUVs are also shown. Only about 5 % of the Hb molecules oxidized during the same time 
period (30 min) in the samples without SUVs, yielding only low levels of metHb, hemichrome 
and choleglobin in samples without SUVs. These data also indicated that the time-dependent 
disappearance of oxyHb and the appearance of metHb, hemichrome and choleglobin were 
multiphasic. Thus the rate constants for the disappearance of oxyHb, or for the appearance 
of metHb, hemichrome or choleglobin provided a more informative description of the 
oxidation processes under different conditions. 
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Fig 1-S: Freeze fracture electron micrographs of (A) BPS SUVs and (B) BPS LUVs. The scale 
bar is 200 nm. The SUVs were prepared by sonication and the LUVs were prepared by 
extrusion through a 100 nm polycarbonate filter in PEN7.4 buffer. The SUV diameters are 
about 10 - 30 nm. Some larger vesicles were also observed in SUV samples. The LUY 
diameters are about 100 - 130 nm. The micrographs were prepared, as a service, by Lipex 
(Vancouver, Canada). 
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Fig 2-S: Spectra from 500 to 700 nm at 37 °C of (A) 
BPS SUVs (2.4 mg/ml) at t = 0; (B) Hb (0.21 mg/ml) 
at t = 4 days; (C) Hb (0.21 mg/ml) and BPS SUVs 
(2.0 mg/ml) mixture at t = 6 h. Buff er was used as 
blanks to obtain spectra in (A) and (B). BPS SUVs 
was used a blank for (C). PEN7.4 was the buff er in 
all samples. 
111 
Fig 3-S: Freeze fracture electron micrograph of BPS LUVs (20 mg/ml) after incubation with 
Hb (0.21 mg/ml) overnight. The scale bar is 200 nm. Due to the presence of Hb, some of the 
LUVs with diameters about 100 - 130 nm fused to give very large vesicles. 
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Fig 4-S: Comparison of oxyHb oxidation in the presence (filled symbols) and absence (shaded 
symbols) of BPS SUVs: % oxyHb <• ), % metHb (■ ), % hemichrome ("' ) and% choleglobin 
(* ). OxyHb (0.19 mg/ml) was incubated at 37 °C in the presence of BPS SUVs (2.1 mg/ml) 
in PEN7.4 buffer. Spectra were collected every 2 min in the presence of BPS SUVs and every 
10 min in the absence of BPS SUVs. The concentrations of Hb components were analyzed by 
a four-component analysis method, as discussed in text. 
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